GLP-1 Market
LLY $1406.29 ▼ -1.8% NVO $40.70 ▼ -2.2% PFE $28.41 ▼ -1.6% VKTX $26.65 ▼ -0.6% KLRA $12.08 ▼ -3.9% GPCR $18.06 ▼ -2.7% RHHBY $60.95 ▲ +1.1%
Market data delayed up to 20 min · Source: Twelve Data
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

Sinemet CR

Company
VA Office of Research and Development
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
38 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

38 recruiting studies currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Nov 17, 2026

Find a Clinical Trial Near Me

See recruiting studies for Sinemet CR and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT00004847

    Diagnosis of Pheochromocytoma

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 3000 participants Est. completion 2048-11-30 1 site
    Other conditions: Pheochromocytoma, Endocrine Disease, Endocrine Diseases
    View official trial listing →
  • Recruiting NCT NCT03872102

    Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging

    University of Texas Southwestern Medical Center 90 participants Est. completion 2026-12-31 1 site
    Other conditions: Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear Palsy
    View official trial listing →
  • Recruiting NCT NCT04205604

    18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism

    Not yet reported Miguel Pampaloni 50 participants Est. completion 2026-12-01 1 site
    Other conditions: Congenital Hyperinsulinism
    View official trial listing →
  • Recruiting NCT NCT04558112

    Improving Therapeutic Learning for PTSD

    Not yet reported University of Wisconsin, Madison 120 participants Est. completion 2023-12 2 sites
    Other conditions: PTSD, Post Traumatic Stress Disorder
    View official trial listing →
  • Recruiting NCT NCT04735627

    Real-Time Levodopa Level Monitoring in Parkinson Disease

    Not yet reported University of California, San Diego 20 participants Est. completion 2028-02 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT04957095

    Motor Network Physiology

    Not yet reported University of Texas Southwestern Medical Center 120 participants Est. completion 2028-12-01 1 site Stand-alone
    Other conditions: Parkinson Disease, Essential Tremor
    View official trial listing →
  • Recruiting NCT NCT05285683

    The Role of Brain Dopamine in Chronic Pain

    Not yet reported University of Rochester 10 participants Est. completion 2027-12-22 1 site
    Other conditions: Chronic Pain
    View official trial listing →
  • Recruiting NCT NCT05656586

    Udall Project 2 Aim 2A&C

    University of Minnesota 36 participants Est. completion 2028-03-01 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT05711082

    REALITY MONITORING AND DOPAMINE

    Not yet reported Hôpital le Vinatier 39 participants Est. completion 2027-02-28 1 site
    Other conditions: Neurosciences
    View official trial listing →
  • Recruiting NCT NCT05909267

    Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation

    Not yet reported Charite University, Berlin, Germany 165 participants Est. completion 2026-07 1 site
    Other conditions: Depressive Disorder, Major
    View official trial listing →
  • Recruiting NCT NCT06013956

    Personalized Real-Time DBS and PD Mechanisms

    Not yet reported David Escobar 25 participants Est. completion 2028-06-30 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT06075771

    Dopaminergic Therapy for Anhedonia - 2

    Not yet reported Emory University 70 participants Est. completion 2027-01 1 site Stand-alone
    Other conditions: Anhedonia, Depression
    View official trial listing →
  • Recruiting NCT NCT06234995

    Cortical Electrophysiology of Response Inhibition in Parkinson's Disease

    Not yet reported Emory University 80 participants Est. completion 2027-09 2 sites Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT06316232

    DBS and Levodopa for Treating Freezing of Gait in Parkinson's Disease

    Not yet reported IRCCS Istituto delle Scienze Neurologiche di Bologna 20 participants Est. completion 2026-12-31 1 site
    Other conditions: Freezing of Gait, Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT06489483

    Action Regulation Behavioral

    Not yet reported University of Texas Southwestern Medical Center 50 participants Est. completion 2027-11 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT06570824

    rTMS as an Intervention for Levodopa-induced Dyskinesia

    Not yet reported Danish Research Centre for Magnetic Resonance 68 participants Est. completion 2027-12-01 1 site
    Other conditions: Dyskinesia, Drug-Induced, Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT06667726

    An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors

    Not yet reported Mayo Clinic 47 participants Est. completion 2028-05-31 1 site
    Other conditions: Malignant Brain Neoplasm
    View official trial listing →
  • Recruiting NCT NCT06765668

    A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease

    Not yet reported Impax Laboratories, LLC 220 participants Est. completion 2026-08-06 27 sites Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT06772220

    Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease

    Not yet reported Oregon Health and Science University 150 participants Est. completion 2025-12-31 1 site
    Other conditions: Parkinson&Amp;#39;s Disease
    View official trial listing →
  • Recruiting NCT NCT06785298

    Fexofenadine as Adjuvant Therapy in Parkinson Disease

    Not yet reported, Not yet reported Tanta University 46 participants Est. completion 2026-12-20 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT06831500

    Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.

    Not yet reported, Not yet reported Julien Bally 36 participants Est. completion 2026-11 2 sites Stand-alone
    Other conditions: Multi-system Atrophy - Parkinsonian Type, Orthostatic Hypotension, Dysautonomic, Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT06884722

    Brain Mechanisms of Social Perception in Parkinson's Disease

    Not yet reported Hospices Civils de Lyon 83 participants Est. completion 2027-04 1 site
    Other conditions: Social Perception in Parkinson's Disease
    View official trial listing →
  • Recruiting NCT NCT06891781

    Investigating Adaptive Deep Brain Stimulation in Parkinson's Disease Management

    Not yet reported Newronika 104 participants Est. completion 2029-08 1 site
    Other conditions: Parkinson Disease, Idiopathic
    View official trial listing →
  • Recruiting NCT NCT06928519

    Efficacy and Safety of Entacapone Combined With Madopar in the Treatment of Early Parkinson's Disease: An Observational, Multicenter, Case-Control Study

    Yousheng Xiao 216 participants Est. completion 2027-06-30 1 site
    Other conditions: Parkinson Disease (PD)
    View official trial listing →
  • Recruiting NCT NCT06949865

    AI-Enhanced Optimization of Acute Levodopa Challenge Test

    Beijing Tiantan Hospital 2000 participants Est. completion 2026-12-31 1 site
    Other conditions: Vascular Parkinsonism, Drug-induced Parkinsonism, Corticobasal Degeneration (CBD), Parkinson Disease (PD), Dementia With Lewy Body Disease, Progressive Supranuclear Palsy(PSP), Multiple System Atrophy (MSA)
    View official trial listing →
  • Recruiting NCT NCT07151378

    Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease

    Not yet reported University Hospital Tuebingen 150 participants Est. completion 2030-09-22 7 sites Stand-alone
    Other conditions: PARKINSON DISEASE (Disorder)
    View official trial listing →
  • Recruiting NCT NCT07213219

    PET-MRI of Reward System in Parkinson's Disease With RBD

    Not yet reported University Hospital, Clermont-Ferrand 44 participants Est. completion 2029-01-01 3 sites Stand-alone
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Recruiting NCT NCT07229651

    Metformin in Parkinson Disease

    Not yet reported, Not yet reported Tanta University 60 participants Est. completion 2027-09-20 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT07229664

    Vinpocetine in Patients With Parkinsonian Disease

    Not yet reported, Not yet reported Tanta University 60 participants Est. completion 2027-11-20 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT07246278

    Celecoxib in Parkinson Disease as Adjuvant Therapy

    Not yet reported, Not yet reported Tanta University 80 participants Est. completion 2026-11-28 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT07370532

    Etoricoxib in Patients With Parkinsonian Disease

    Not yet reported Ihab Elsayed Hassan 60 participants Est. completion 2027-11-20 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT07432958

    A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations

    Not yet reported Appello Pharmaceuticals, Inc. 150 participants Est. completion 2028-01-03 30 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT07513441

    A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)

    Not yet reported H. Lundbeck A/S 10 participants Est. completion 2027-05-31 4 sites Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT07725562

    VG081821AC Tablets for Early to Mid-stage Parkinson's Disease

    Not yet reported, Not yet reported Zhejiang Vimgreen Pharmaceuticals, Ltd. 152 participants Est. completion 2027-10-31 1 site
    Other conditions: Parkinson Disease (PD)
    View official trial listing →
  • Recruiting NCT NCT07797790

    Real-world Patient Experiences With Inbrija®

    Merz Therapeutics GmbH 120 participants Est. completion 2027-09 2 sites
    Other conditions: Parkinson Disease (PD), Parkinson's Disease, Off Episodes of Parkinson Disease
    View official trial listing →
  • Recruiting NCT NCT07810296

    Comparison of Benzhexol and Procyclidine for Tremor in Tremor-Predominant Parkinson's Disease

    Not yet reported safia bano 88 participants Est. completion 2027-07 1 site Stand-alone
    Other conditions: Parkinson Disease (PD)
    View official trial listing →
  • Recruiting NCT NCT07839793

    A 12-Week Study of Flexilev With the OraFID Device and App in Parkinson's Patients

    Not yet reported Navamedic AB 58 participants Est. completion 2027-06-30 5 sites Stand-alone
    Other conditions: PARKINSON DISEASE (Disorder)
    View official trial listing →
  • Recruiting NCT NCT07935889

    Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 Trial

    Not yet reported Mayo Clinic 292 participants Est. completion 2035-11-30 8 sites
    Other conditions: Glioblastoma, IDH-Wildtype
    View official trial listing →
  • Completed NCT NCT00001849

    New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome

    Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 95 participants Est. completion 2019-04-26 1 site
    Other conditions: Cushing Syndrome, Endocrine Disease
    View official trial listing →
  • Completed NCT NCT00001928

    Intravenous Levodopa for the Diagnosis of Parkinson's Disease

    National Institute of Neurological Disorders and Stroke (NINDS) 25 participants Est. completion 2000-07 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00001929

    Treatment of Parkinson's Disease With Eliprodil

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 20 participants Est. completion 2001-01 1 site
    Other conditions: Movement Disorders, Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00004576

    Study of LY300164 for the Treatment of Parkinson's Disease

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 20 participants Est. completion 2000-08 1 site
    Other conditions: Dyskinesias, Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00004733

    Timing of Levodopa Treatment in Parkinson's Disease

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) Est. completion 2004-02 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00006077

    Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 50 participants Est. completion 2003-07 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00006337

    KW-6002 to Treat Parkinson's Disease

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 16 participants Est. completion 2002-01 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00009048

    EMD 128130 for the Treatment of Parkinson's Disease

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 30 participants Est. completion 2003-12 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00013624

    Riluzole to Treat Parkinson's Disease

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 20 participants Est. completion 2005-03 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00024622

    PET Scanning in Parkinson s Disease

    National Institute of Mental Health (NIMH) 502 participants 1 site
    Other conditions: Schizophrenia, Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00036296

    Effects of Talampanel on Patients With Advanced Parkinson's Disease

    Not yet reported, Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 22 participants Est. completion 2007-02
    Other conditions: Dyskinesias, Parkinson Disease, Movement Disorders
    View official trial listing →
  • Completed NCT NCT00040209

    JP-1730 to Treat Parkinson's Disease

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 30 participants Est. completion 2005-07 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00076674

    Levetiracetam Treatment of L-dopa Induced Dyskinesias

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 40 participants Est. completion 2005-10 1 site
    Other conditions: Dyskinesias, Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00086294

    ACP-103 to Treat Parkinson's Disease

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 40 participants Est. completion 2007-11-15 1 site
    Other conditions: Parkinson's Disease, Dyskinesias
    View official trial listing →
  • Completed NCT NCT00089622

    Lisuride Patch to Treat Parkinson's Disease

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 40 participants Est. completion 2007-03-31 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00096720

    Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease

    Not yet reported Institute for Neurodegenerative Disorders 112 participants Est. completion 2007-05 13 sites
    Other conditions: Parkinson Disease, Parkinsonian Syndrome
    View official trial listing →
  • Completed NCT NCT00099268

    Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy

    Not yet reported Novartis Pharmaceuticals 747 participants Est. completion 2008-11 73 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT00102284

    Neuromodulation and Language Acquisition (Project Stage Ia)

    Not yet reported University Hospital Muenster 100 participants Est. completion 2005-04 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00102869

    Dopaminergic Enhancement of Learning and Memory in Aphasia

    Not yet reported University Hospital Muenster 12 participants Est. completion 2008-12 1 site
    Other conditions: Cerebrovascular Accident, Aphasia
    View official trial listing →
  • Completed NCT NCT00103805

    Improved Language Acquisition With Levodopa

    Not yet reported University Hospital Muenster 20 participants Est. completion 2005-08 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00108667

    Talampanel to Treat Parkinson's Disease

    Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 40 participants Est. completion 2006-02 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT00111371

    Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia

    Not yet reported University Hospital Muenster 100 participants Est. completion 2015-10 1 site
    Other conditions: Dyslexia
    View official trial listing →
  • Completed NCT NCT00125567

    Stalevo in Early Wearing-Off Patients

    Not yet reported Orion Corporation, Orion Pharma 223 participants Est. completion 2009-03 19 sites Stand-alone
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00129181

    Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease

    Not yet reported Institute for Neurodegenerative Disorders 30 participants Est. completion 2007-01 9 sites
    Other conditions: Parkinson Disease, Parkinsonian Syndrome
    View official trial listing →
  • Completed NCT NCT00134251

    Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease

    Not yet reported Solvay Pharmaceuticals 10 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00134784

    Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression

    Not yet reported Institute for Neurodegenerative Disorders 142 participants Est. completion 2007-05 Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00134966

    A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa

    Not yet reported Novartis 493 participants Est. completion 2007-09 60 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00139867

    A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease

    Not yet reported UCB Pharma Est. completion 2004-05 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00139880

    A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease

    Not yet reported UCB Pharma Est. completion 2005-08 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00141518

    Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact

    Not yet reported AbbVie (prior sponsor, Abbott) 77 participants Est. completion 2011-04 Stand-alone
    Other conditions: Advanced Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00143026

    Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States

    Not yet reported Novartis 184 participants Est. completion 2006-06 18 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00144209

    Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome

    Not yet reported Boehringer Ingelheim 58 participants Est. completion 2005-02 6 sites
    Other conditions: Restless Legs Syndrome
    View official trial listing →
  • Completed NCT NCT00148512

    A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations

    Not yet reported Boehringer Ingelheim 254 participants Est. completion 2005-02 50 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00160576

    Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias

    Not yet reported UCB Pharma 30 participants Est. completion 2004-11
    Other conditions: Idiopathic Parkinson Disease
    View official trial listing →
  • Terminated NCT NCT00174239

    Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.

    Not yet reported Pfizer 220 participants Est. completion 2005-09 14 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00199355

    A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

    Not yet reported Kyowa Kirin Co., Ltd. 75 participants Est. completion 2006-03 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00199368

    An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018

    Not yet reported Kyowa Kirin, Inc. 1100 participants Est. completion 2007-05 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT00199381

    An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001

    Not yet reported Kyowa Kirin, Inc. 504 participants Est. completion 2008-10 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00199394

    A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease

    Not yet reported Kyowa Kirin Co., Ltd. 405 participants Est. completion 2005-11 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00199407

    A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

    Not yet reported Kyowa Kirin, Inc. 230 participants Est. completion 2006-01 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00199420

    A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa

    Not yet reported Kyowa Kirin, Inc. 580 participants Est. completion 2005-12 2 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00200447

    An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)

    Not yet reported Molecular NeuroImaging 3 participants Est. completion 2004-09
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00203034

    Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 472 participants Est. completion 2003-01 4 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00203060

    Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa

    Not yet reported Teva Neuroscience, Inc. 404 participants Est. completion 2000-07
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00203164

    Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 254 participants Est. completion 2006-09 6 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00203177

    Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.

    Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 254 participants 8 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00203957

    Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa

    Not yet reported University of Chicago 10 participants Est. completion 2007-02 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT00208611

    Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease

    Not yet reported, Not yet reported Emory University 57 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00218023

    Medications for Stopping Cocaine Dependence and Preventing Relapse

    Not yet reported The University of Texas Health Science Center, Houston 101 participants Est. completion 2012-04 1 site Stand-alone
    Other conditions: Cocaine Abuse, Cocaine-Related Disorders
    View official trial listing →
  • Completed NCT NCT00218075

    Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence

    Not yet reported The University of Texas Health Science Center, Houston 200 participants Est. completion 2007-10 1 site
    Other conditions: Cocaine Abuse, Cocaine-Related Disorders
    View official trial listing →
  • Completed NCT NCT00219284

    Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease

    Not yet reported Novartis Pharmaceuticals 359 participants Est. completion 2008-07 42 sites Stand-alone
    Other conditions: Parkinson's Disease With End of Dose Wearing Off
    View official trial listing →
  • Completed NCT NCT00223691

    Treatment of Orthostatic Hypotension in Autonomic Failure

    Not yet reported Vanderbilt University 389 participants Est. completion 2017-01 1 site Stand-alone
    Other conditions: Autonomic Failure, Orthostatic Hypotension
    View official trial listing →
  • Completed NCT NCT00224263

    Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease

    Not yet reported Xuanwu Hospital, Beijing 360 participants Est. completion 2008-02 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00228150

    Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease

    Not yet reported Sanofi 564 participants Est. completion 2006-04 13 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00239564

    Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease

    Not yet reported, Not yet reported Impax Laboratories, LLC 12 participants Est. completion 2007-12 2 sites Stand-alone
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00244387

    Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa

    Not yet reported UCB Pharma 506 participants Est. completion 2005-07 1 site
    Other conditions: Parkinson Disease, Idiopathic
    View official trial listing →
  • Completed NCT NCT00245700

    Adherence of Stalevo, Entacapone and Levodopa

    South Glasgow University Hospitals NHS Trust 14 participants Est. completion 2006-07 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00247247

    Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.

    Not yet reported Orion Corporation, Orion Pharma 300 participants Est. completion 2005-06 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00253084

    Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease

    Not yet reported Impax Laboratories, LLC 12 participants Est. completion 2007-12 2 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00272688

    Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit

    Not yet reported University Hospital, Akershus 10 participants Est. completion 2009-05 2 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00282152

    Deep Brain Stimulation (DBS) for Early Stage Parkinson's Disease (PD)

    Not yet reported Vanderbilt University Medical Center 37 participants Est. completion 2015-10 Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00286897

    The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

    Not yet reported Eisai Limited 702 participants Est. completion 2007-08 118 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT00291733

    Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease

    Not yet reported 1st Hospital of Social Security Services 50 participants Est. completion 2007-10 1 site
    Other conditions: Levodopa Induced Dyskinesia
    View official trial listing →
  • Terminated NCT NCT00296959

    Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease

    Not yet reported University Health Network, Toronto 20 participants Est. completion 2007-03 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00302146

    Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations

    National Human Genome Research Institute (NHGRI) 64 participants 1 site
    Other conditions: Parkinson Disease, Gaucher Disease
    View official trial listing →
  • Status unknown NCT NCT00306124

    Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment

    Not yet reported University Hospital Muenster 120 participants Est. completion 2008-03 1 site
    Other conditions: Alzheimer's Disease, Mild Cognitive Impairment, Healthy
    View official trial listing →
  • Completed NCT NCT00307450

    Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease

    Not yet reported Technische Universität Dresden 34 participants Est. completion 2009-07 2 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00314288

    Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia

    Not yet reported EMD Serono 360 participants Est. completion 2003-07 51 sites
    Other conditions: Parkinson's Disease, Dyskinesia
    View official trial listing →
  • Completed NCT NCT00331149

    A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's

    Not yet reported GlaxoSmithKline 343 participants Est. completion 2007-08-29 81 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00335153

    Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease

    Not yet reported AbbVie (prior sponsor, Abbott) 354 participants Est. completion 2012-06 83 sites Stand-alone
    Other conditions: Advanced Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00357994

    Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

    Not yet reported AbbVie (prior sponsor, Abbott) 36 participants Est. completion 2011-10 15 sites Stand-alone
    Other conditions: Advanced Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT00360308

    Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

    Not yet reported Eisai Limited 723 participants Est. completion 2008-04 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT00360412

    A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

    Not yet reported Eisai Inc. 997 participants Est. completion 2008-04 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00360568

    Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects

    Not yet reported AbbVie (prior sponsor, Abbott) 62 participants Est. completion 2012-10 22 sites Stand-alone
    Other conditions: Dyskinesias, Parkinson's Disease, Severe Motor Fluctuations
    View official trial listing →
  • Completed NCT NCT00363727

    Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's

    Not yet reported GlaxoSmithKline 209 participants Est. completion 2006-01 69 sites
    Other conditions: Parkinson's Disease, Parkinson Disease, Dyskinesias
    View official trial listing →
  • Completed NCT NCT00366184

    Influence of Theta Burst Stimulation and Carbidopa-Levodopa on Motor Performance in Stroke Patients

    National Institute of Neurological Disorders and Stroke (NINDS) 20 participants Est. completion 2010-05-26 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT00368108

    Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations

    Not yet reported Eisai Inc. 752 participants Est. completion 2008-01 114 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00373087

    COMT Polymorphism and Entacapone Efficacy

    Not yet reported Assistance Publique - Hôpitaux de Paris 60 participants Est. completion 2009-11 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00381472

    Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa

    Not yet reported GlaxoSmithKline 393 participants Est. completion 2004-12 76 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00391898

    Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off

    Not yet reported Novartis 95 participants Est. completion 2008-06 26 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00399477

    A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease

    Not yet reported Teva Neuroscience, Inc. 200 participants Est. completion 2007-07 Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00406029

    Dyskinesia in Parkinson's Disease (Study P04501)

    Not yet reported Merck Sharp & Dohme LLC 253 participants Est. completion 2008-11-03
    Other conditions: Parkinson Disease, Movement Disorders, Central Nervous System Diseases, Neurodegenerative Diseases, Brain Diseases
    View official trial listing →
  • Completed NCT NCT00406588

    SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations

    Not yet reported Solvay Pharmaceuticals 295 participants Est. completion 2008-05 87 sites Stand-alone
    Other conditions: Advanced Stage Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00415740

    Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

    Not yet reported Novartis 42 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00415831

    Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

    Not yet reported Novartis 42 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00415844

    Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers

    Not yet reported Novartis 42 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00415922

    Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers

    Not yet reported Novartis 42 participants 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT00431366

    Sequence Effect in Parkinson's Disease

    National Institute of Neurological Disorders and Stroke (NINDS) 24 participants Est. completion 2008-12-24 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00432393

    Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy

    Not yet reported Shahid Beheshti University of Medical Sciences Est. completion 2003-04 1 site
    Other conditions: Nonarteritic Anterior Ischemic Optic Neuropathy
    View official trial listing →
  • Completed NCT NCT00438607

    Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease

    Not yet reported Biogen 83 participants Est. completion 2009-04 15 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT00439049

    Substance Abuse Pre-Treatment Screening Study

    The University of Texas Health Science Center, Houston 7500 participants Est. completion 2026-06 1 site
    Alcohol use disorder Other conditions: Cocaine Abuse, Cocaine Dependence, Opiate Dependence, Substance Abuse
    View official trial listing →
  • Withdrawn NCT NCT00451633

    The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations

    Not yet reported Eisai Inc. 5 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00455507

    A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

    Not yet reported Kyowa Kirin Co., Ltd. 363 participants Est. completion 2008-08 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00456586

    12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa

    Not yet reported Kyowa Kirin, Inc. 180 participants Est. completion 2003-06 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00456794

    12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa

    Not yet reported Kyowa Kirin, Inc. 325 participants Est. completion 2003-10 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00460954

    A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects

    Bristol-Myers Squibb 20 participants Est. completion 2007-08 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00462007

    Study to Evaluate Initiation of Stalevo in Early Wearing-off

    Not yet reported Orion Corporation, Orion Pharma 115 participants Est. completion 2007-12 20 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00466167

    Pivotal Study in Advanced Parkinsons Disease Patients

    Not yet reported Boehringer Ingelheim 517 participants 76 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00467597

    Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)

    US Department of Veterans Affairs 36 participants Est. completion 2013-10 1 site
    Other conditions: Dyskinesias, Movement Disorders, Parkinson Disease
    View official trial listing →
  • Terminated NCT NCT00477802

    Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease

    Not yet reported University of Cincinnati 8 participants Est. completion 2008-12 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00485069

    REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study

    Not yet reported GlaxoSmithKline 123 participants Est. completion 2009-12 22 sites
    Other conditions: Parkinson Disease, Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00491998

    PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets

    Not yet reported, Not yet reported Vernalis (R&D) Ltd 27 participants Est. completion 2007-11 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00501969

    An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease

    Not yet reported UCB Pharma 395 participants Est. completion 2008-12 53 sites
    Other conditions: Advanced Stage Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT00505622

    Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations

    Not yet reported Eisai Limited 328 participants Est. completion 2008-04 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00505843

    A Study of MK0657 in Parkinson's Disease Patients (0657-006)

    Not yet reported Merck Sharp & Dohme LLC 18 participants Est. completion 2008-02
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00507715

    Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk

    Not yet reported Rottapharm Spain 18 participants Est. completion 2006-11 1 site
    Other conditions: Parkinson's Disease, Idiopathic
    View official trial listing →
  • Completed NCT NCT00537017

    Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)

    Not yet reported Merck Sharp & Dohme LLC 140 participants Est. completion 2009-11-19
    Other conditions: Parkinson Disease, Neurodegenerative Diseases, Central Nervous System Diseases, Movement Disorders, Brain Diseases
    View official trial listing →
  • Completed NCT NCT00537485

    A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients

    Not yet reported, Not yet reported Otsuka Pharmaceutical Co., Ltd. 180 participants Est. completion 2009-12 6 sites
    Other conditions: Early Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00552474

    Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease

    Not yet reported Abbott Medical Devices 136 participants Est. completion 2016-11 15 sites
    Other conditions: Parkinson Disease, Movement Disorders
    View official trial listing →
  • Completed NCT NCT00558337

    Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease

    Not yet reported Osmotica Pharmaceutical US LLC 78 participants Est. completion 2008-12 9 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00560508

    A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period

    Not yet reported, Not yet reported Boehringer Ingelheim 112 participants 19 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Terminated NCT NCT00562198

    PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding

    Not yet reported Orion Corporation, Orion Pharma 16 participants Est. completion 2008-05 5 sites
    Other conditions: Parkinson´s Disease
    View official trial listing →
  • Completed NCT NCT00582673

    Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa

    Not yet reported Novartis 31 participants 5 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00590122

    Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study

    Not yet reported Baylor College of Medicine 20 participants Est. completion 2008-11 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00599339

    Transdermal Rotigotine User Surveillance Study

    UCB Pharma 2195 participants Est. completion 2014-04 211 sites
    Other conditions: Idiopathic Parkinson Disease
    View official trial listing →
  • Withdrawn NCT NCT00601978

    Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off

    Not yet reported Novartis Pharmaceuticals Est. completion 2009-11
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00605553

    Study to Evaluate SYN115 in Parkinson's Disease

    Not yet reported Biotie Therapies Inc. 30 participants Est. completion 2009-05 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT00607451

    Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia

    Not yet reported, Not yet reported Neurim Pharmaceuticals Ltd. 8 participants Est. completion 2016-08-27 1 site
    Other conditions: Levodopa-induced Dyskinesia
    View official trial listing →
  • Completed NCT NCT00610103

    Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy

    Not yet reported Kyowa Kirin Co., Ltd. 16 participants Est. completion 2008-10 4 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00613301

    Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa

    Boehringer Ingelheim 416 participants 119 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • No Longer Available NCT NCT00624741

    Compassionate Use Study of Pergolide in Patients With Parkinson's Disease

    Bausch Health Americas, Inc.
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00625547

    A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS

    Not yet reported Pfizer 361 participants Est. completion 2004-12 50 sites Stand-alone
    Other conditions: Restless Legs Syndrome
    View official trial listing →
  • Completed NCT NCT00627640

    Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa

    Not yet reported Newron Pharmaceuticals SPA 549 participants Est. completion 2012-03 121 sites
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00632762

    Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)

    Not yet reported University Hospital, Toulouse 80 participants Est. completion 2011-01 5 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00634556

    Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)

    Not yet reported Washington University School of Medicine 49 participants Est. completion 2010-10 1 site Stand-alone
    Other conditions: Tourette Syndrome
    View official trial listing →
  • Terminated NCT NCT00642356

    Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off

    Not yet reported Novartis 14 participants Est. completion 2009-05 21 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT00647140

    Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer

    Not yet reported Assistance Publique - Hôpitaux de Paris 29 participants Est. completion 2010-02 1 site
    Other conditions: Thyroid Neoplasm, Thyroid Carcinoma, Medullary Carcinoma
    View official trial listing →
  • Completed NCT NCT00660387

    Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects

    Not yet reported AbbVie (prior sponsor, Abbott) 35 participants Est. completion 2011-10 14 sites Stand-alone
    Other conditions: Advanced Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00660673

    Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease

    Not yet reported AbbVie 262 participants Est. completion 2021-11-30 61 sites Stand-alone
    Other conditions: Advanced Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00664157

    Facial Expression Recognition of Emotion and Categorization of Emotional Words in Parkinson's Disease. Impact of L-Dopa and Deep Brain Stimulation of Subthalamic Nucleus

    Not yet reported University Hospital, Clermont-Ferrand 80 participants Est. completion 2009-10 1 site
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT00664209

    Treating H. Pylori in Parkinson's Patients With Motor Fluctuations

    Not yet reported University of California, Los Angeles 64 participants Est. completion 2012-06 1 site
    Other conditions: Parkinson's Disease, Helicobacter Infections, Motor Fluctuations
    View official trial listing →
  • Completed NCT NCT00666653

    Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease

    Not yet reported Oregon Health and Science University 13 participants Est. completion 2007-05 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00692328

    Expectation and Response to Levodopa and Acupuncture in Parkinson's Disease

    Not yet reported Oregon Health and Science University 63 participants Est. completion 2007-02 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00713583

    Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence

    Not yet reported The University of Texas Health Science Center, Houston 85 participants Est. completion 2011-12 1 site Stand-alone
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT00715520

    Neurobiological Principles Applied to the Rehabilitation of Stroke Patients

    Not yet reported Emory University 33 participants Est. completion 2016-09 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Withdrawn NCT NCT00758368

    Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease

    Not yet reported Oregon Health and Science University Est. completion 2011-06 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT00762814

    The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease

    Not yet reported Washington University School of Medicine 4 participants Est. completion 2009-06 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00775853

    Biomarkers of Risk of Parkinson Disease

    National Institute of Neurological Disorders and Stroke (NINDS) 89 participants Est. completion 2023-01-11 1 site
    Other conditions: Parkinson Disease, Autonomic Nervous System Diseases, Pure Autonomic Failure
    View official trial listing →
  • Completed NCT NCT00789672

    Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia

    Not yet reported Jaeb Center for Health Research 33 participants Est. completion 2009-12 1 site
    Other conditions: Amblyopia
    View official trial listing →
  • Terminated NCT NCT00804479

    The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)

    University of Rochester 222 participants Est. completion 2004-03 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00812760

    Effect of Levodopa on Human Multifocal Electroretinogram

    Not yet reported Medical University of Vienna 20 participants Est. completion 2003-10 1 site Stand-alone
    Other conditions: Retinal Diseases
    View official trial listing →
  • Completed NCT NCT00823836

    Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease

    Not yet reported GlaxoSmithKline 302 participants Est. completion 2010-12 54 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00829439

    Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome

    Not yet reported Boston Children's Hospital 16 participants Est. completion 2010-06 1 site Stand-alone
    Other conditions: Angelman Syndrome
    View official trial listing →
  • Completed NCT NCT00845000

    Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)

    Not yet reported Merck Sharp & Dohme LLC 12 participants Est. completion 2010-05-14 Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00869791

    A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa

    Not yet reported Impax Laboratories, LLC 27 participants Est. completion 2009-06 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00880620

    A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease

    Not yet reported Impax Laboratories, LLC 381 participants Est. completion 2010-11 60 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00888004

    Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients

    Not yet reported Novartis 28 participants 5 sites
    Other conditions: Parkinson's Disease, L-dopa Induced Dyskinesia
    View official trial listing →
  • Completed NCT NCT00888186

    Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics

    Not yet reported Uppsala University 5 participants Est. completion 2008-05 1 site Stand-alone
    Other conditions: Parkinson Disease, Dyskinesias
    View official trial listing →
  • Terminated NCT NCT00903838

    A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.

    Not yet reported Abbott Products 37 participants Est. completion 2011-05 9 sites
    Other conditions: Advanced Stage Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00906828

    Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors

    Not yet reported Uppsala University 10 participants Est. completion 2009-11 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT00912977

    Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia

    Oregon Health and Science University 10 participants Est. completion 2010-06 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00914134

    Duodenal Levodopa Infusion, Quality of Life and Autonomic Nervous System in Parkinson's Disease

    Not yet reported University of Helsinki 12 participants Est. completion 2011-01 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00914602

    An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease Subjects

    Not yet reported, Not yet reported XenoPort, Inc. 14 participants Est. completion 2010-01 2 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00918177

    An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease

    Not yet reported Intec Pharma Ltd. 72 participants 7 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00941265

    Effect of Dopaminergic Medication on Recovery of Aphasia

    Not yet reported University Hospital, Geneva 12 participants Est. completion 2009-08 1 site
    Other conditions: Aphasia
    View official trial listing →
  • Withdrawn NCT NCT00947037

    Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study

    Not yet reported Intec Pharma Ltd. 5 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00955045

    A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy

    Not yet reported, Not yet reported Kyowa Kirin, Inc. Est. completion 2003-10 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00955526

    Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa

    Not yet reported Kyowa Kirin Co., Ltd. 373 participants Est. completion 2011-02 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00957203

    Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients

    Not yet reported Kyowa Kirin Co., Ltd. 308 participants Est. completion 2012-03 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00974974

    A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).

    Not yet reported Impax Laboratories, LLC 471 participants Est. completion 2011-03 73 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT00986414

    Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

    Not yet reported Novartis 260 participants 47 sites
    Other conditions: Parkinson Disease, Dyskinesias
    View official trial listing →
  • Withdrawn NCT NCT01003002

    Natural History of Levodopa-Induced Dyskinesia (LID)

    Oregon Health and Science University Est. completion 2020-12 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01023282

    Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients

    Not yet reported NeuroSearch A/S 22 participants Est. completion 2011-04 2 sites
    Other conditions: Parkinson's Disease, Tolerability
    View official trial listing →
  • Completed NCT NCT01026428

    A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics

    Not yet reported, Not yet reported Newron Pharmaceuticals SPA 24 participants 2 sites Stand-alone
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01044992

    Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study

    Not yet reported University Hospital, Toulouse 38 participants Est. completion 2006-05 4 sites Stand-alone
    Other conditions: Multisystemic Atrophy
    View official trial listing →
  • Completed NCT NCT01049984

    Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease

    Not yet reported Teva Neuroscience, Inc. 328 participants Est. completion 2012-10 58 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01052948

    The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events

    Pfizer 86939 participants Est. completion 2009-12
    Other conditions: Parkinson's Disease, Hyperprolactinemia
    View official trial listing →
  • Completed NCT NCT01064739

    Renal Salt Handling in Postural Tachycardia Syndrome Following Dietary Dopa Administration

    Not yet reported Vanderbilt University 14 participants Est. completion 2012-12 1 site
    Other conditions: Healthy Participants
    View official trial listing →
  • Completed NCT NCT01070628

    Levodopa Concentration Profile With Stalevo 75/125 mg

    Not yet reported Orion Corporation, Orion Pharma 20 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01092065

    Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia

    Not yet reported Novartis 23 participants Est. completion 2011-07 4 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01096186

    An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease

    Not yet reported Impax Laboratories, LLC 617 participants Est. completion 2011-10 81 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01103011

    Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611

    Not yet reported NeuroDerm Ltd. 8 participants Est. completion 2010-10 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01113320

    Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects

    Not yet reported Newron Pharmaceuticals SPA 26 participants Est. completion 2012-01 11 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01130493

    A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066

    Not yet reported Impax Laboratories, LLC 110 participants Est. completion 2012-01 24 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01135407

    Visual Selective Attention in Parkinson's Disease

    University Hospital, Grenoble 36 participants Est. completion 2010-07 1 site
    Other conditions: Visual Attention in Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01140841

    A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving Levodopa

    Bausch Health Americas, Inc. 40 participants Est. completion 2010-11 4 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01142739

    Phosphorylation of ERK1/2 in Patients With Parkinson's Disease

    University Hospital, Bordeaux 30 participants Est. completion 2012-07 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT01149811

    A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease

    Bausch Health Americas, Inc. 27 participants Est. completion 2010-11 4 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01154166

    A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa

    Not yet reported GlaxoSmithKline 347 participants Est. completion 2011-09-29 18 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT01171313

    A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects

    Not yet reported XenoPort, Inc. 35 participants Est. completion 2011-12 12 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01173731

    Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

    Not yet reported Novartis Pharmaceuticals 66 participants Est. completion 2013-10 22 sites
    Other conditions: Parkinson Disease, Dyskinesia, Drug-Induced, Levodopa
    View official trial listing →
  • Completed NCT NCT01174758

    Development of an Instrumented System to Measure Mobility in Parkinson's Disease

    Oregon Health and Science University 160 participants Est. completion 2014-10 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01176435

    Trial of L-DOPA as a Treatment to Improve Vision in Albinism

    Not yet reported University of Minnesota 45 participants Est. completion 2014-12 1 site
    Other conditions: Albinism
    View official trial listing →
  • Completed NCT NCT01187966

    Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease

    Not yet reported Newron Pharmaceuticals SPA 669 participants Est. completion 2009-02
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01190813

    Levodopa for the Treatment of Residual Amblyopia

    Not yet reported Jaeb Center for Health Research 139 participants Est. completion 2014-04 1 site
    Other conditions: Amblyopia
    View official trial listing →
  • Completed NCT NCT01191944

    Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients

    Not yet reported Boehringer Ingelheim 475 participants Est. completion 2012-01 20 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT01211587

    A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease

    Not yet reported Newron Pharmaceuticals SPA 103 participants 15 sites
    Other conditions: Parkinson's Disease With Cognitive Impairments
    View official trial listing →
  • Completed NCT NCT01218425

    Dopaminergic Modulation of Cognition and Psychomotor Function

    Not yet reported Maastricht University Medical Center 20 participants Est. completion 2012-06 1 site Stand-alone
    Other conditions: Dopamine Activity, Episodic Memory Consolidation, Response Preparation
    View official trial listing →
  • Withdrawn NCT NCT01218919

    Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study

    Abbott Medical Devices Est. completion 2013-12
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT01227655

    Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.

    Not yet reported Bial - Portela C S.A. 427 participants Est. completion 2012-07 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01229332

    A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients

    Not yet reported, Not yet reported NeuroDerm Ltd. 24 participants Est. completion 2011-11 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01268891

    Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea

    Not yet reported H. Lundbeck A/S 132 participants
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01281475

    A Trial of Levodopa in Angelman Syndrome

    Not yet reported, Not yet reported Wen-Hann Tan 67 participants Est. completion 2015-07 7 sites Stand-alone
    Other conditions: Angelman Syndrome
    View official trial listing →
  • Completed NCT NCT01283594

    Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off

    Not yet reported, Not yet reported Biotie Therapies Inc. 420 participants Est. completion 2012-10 61 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01286935

    18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD

    Not yet reported Newron Pharmaceuticals SPA 544 participants Est. completion 2010-08
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01291537

    Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients

    Not yet reported Poitiers University Hospital 56 participants 20 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01296464

    Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens

    Not yet reported Orion Corporation, Orion Pharma 27 participants Est. completion 2011-07 5 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01327261

    Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy Volunteers

    Not yet reported University of Buenos Aires 24 participants Est. completion 2009-12 Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT01330290

    Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support

    UCB Pharma 148 participants Est. completion 2012-08 54 sites
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01336088

    ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease

    Not yet reported Addex Pharma S.A. 83 participants Est. completion 2012-02 25 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT01338662

    Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist

    Seoul National University Hospital 500 participants Est. completion 2022-04 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Withdrawn NCT NCT01351168

    Use of Zolpidem in Parkinson's Disease

    Not yet reported Rush University Medical Center 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01352819

    Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Disease Study

    Abbott Medical Devices 21 participants Est. completion 2013-12 6 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT01361373

    Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study

    Not yet reported Shaare Zedek Medical Center 50 participants Est. completion 2012-08 1 site
    Other conditions: Dystonic Cerebral Palsy
    View official trial listing →
  • Completed NCT NCT01385592

    Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

    Not yet reported Novartis Pharmaceuticals 78 participants Est. completion 2012-09 28 sites
    Other conditions: Dyskinesias, Parkinson Disease, Movement Disorders, Parkinsonian Disorders
    View official trial listing →
  • Completed NCT NCT01393457

    Cognitive Remediation for Cocaine Dependence

    Not yet reported The University of Texas Health Science Center, Houston 119 participants Est. completion 2017-02 1 site
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT01397422

    Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)

    Not yet reported, Not yet reported Adamas Pharmaceuticals, Inc. 83 participants Est. completion 2013-10 33 sites
    Other conditions: Dyskinesia, Levodopa Induced Dyskinesia, Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01399905

    High and Low Dose Carbidopa Treatment of Parkinson's Disease

    Not yet reported Oregon Health and Science University 14 participants Est. completion 2011-05 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01411137

    Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study

    Not yet reported Impax Laboratories, LLC 43 participants Est. completion 2013-03 8 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01429077

    Augmenting Language Therapy for Aphasia: Levodopa

    Not yet reported, Not yet reported Shirley Ryan AbilityLab 36 participants Est. completion 2012-03 1 site
    Cardiovascular disease Other conditions: Nonfluent Aphasia
    View official trial listing →
  • Completed NCT NCT01429207

    Capturing Parkinson's Disease Medication Side Effects During Daily Activities

    Great Lakes NeuroTechnologies Inc. 15 participants 1 site
    Other conditions: Parkinson's Disease, Dyskinesia
    View official trial listing →
  • Completed NCT NCT01437293

    Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)

    Not yet reported New York State Psychiatric Institute 15 participants Est. completion 2012-04 1 site
    Other conditions: Cocaine Abuse
    View official trial listing →
  • Completed NCT NCT01468012

    Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence

    Not yet reported, Not yet reported New York State Psychiatric Institute 23 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT01470859

    The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease

    Not yet reported Huashan Hospital 30 participants Est. completion 2014-08 1 site
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01474421

    Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease

    Not yet reported Novartis Pharmaceuticals 71 participants Est. completion 2013-02-21 24 sites
    Other conditions: Dyskinesias, Drug-induced
    View official trial listing →
  • Completed NCT NCT01479127

    Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease

    Not yet reported AbbVie (prior sponsor, Abbott) 8 participants Est. completion 2012-07 Stand-alone
    Other conditions: Advanced Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01479530

    Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China

    Not yet reported H. Lundbeck A/S 321 participants Est. completion 2013-06 18 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01484184

    Study to Assess Safety, Tolerability and MTD of a Central Pattern Generator-activating Tritherapy (SPINALON) in Patients With Chronic Spinal Cord Injury

    Not yet reported, Not yet reported Nordic Life Science Pipeline Inc. 50 participants Est. completion 2015-08 1 site
    Other conditions: Spinal Cord Injury
    View official trial listing →
  • Completed NCT NCT01484990

    A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease

    Not yet reported AbbVie 19 participants Est. completion 2010-09 Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT01486628

    Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers

    Not yet reported NeuroDerm Ltd. 36 participants Est. completion 2013-06-13 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01491529

    Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

    Not yet reported Novartis Pharmaceuticals 154 participants Est. completion 2013-04 39 sites
    Other conditions: Dyskinesias, Parkinson Disease, Movement Disorders, Parkinsonian Disorders, Anti-Dyskinesia Agents
    View official trial listing →
  • Completed NCT NCT01491932

    Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias

    Not yet reported Novartis Pharmaceuticals 129 participants Est. completion 2013-10 32 sites
    Other conditions: Dyskinesias, Parkinson Disease, Movement Disorders, Parkinsonian Disorders, Anti-Dyskinesia Agents
    View official trial listing →
  • Completed NCT NCT01494532

    A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease

    Not yet reported GlaxoSmithKline 352 participants Est. completion 2014-11-18 52 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Withdrawn NCT NCT01500707

    Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235)

    Not yet reported Merck Sharp & Dohme LLC Est. completion 2013-07
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01515410

    Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations

    Not yet reported Depomed 34 participants Est. completion 2012-10 7 sites Stand-alone
    Other conditions: Parkinson's Disease, Motor Fluctuations
    View official trial listing →
  • Completed NCT NCT01519284

    Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic

    Not yet reported Bial - Portela C S.A. 82 participants Est. completion 2011-06 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT01528592

    PharmacoMRI of Parkinson Disease

    Not yet reported Northwestern University 18 participants Est. completion 2012-07 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01533077

    Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa

    Not yet reported Bial - Portela C S.A. 18 participants Est. completion 2010-02 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT01533116

    Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide

    Not yet reported Bial - Portela C S.A. 52 participants Est. completion 2010-03 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Terminated NCT NCT01536015

    Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction

    Not yet reported UCB Pharma 25 participants Est. completion 2013-10 26 sites
    Other conditions: Advanced Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01538329

    Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease

    Not yet reported University Hospital, Toulouse 210 participants Est. completion 2019-02-26 18 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT01545856

    Cardiovascular Events in Parkinson's Disease Patients

    GlaxoSmithKline 1 participants Est. completion 2011-11
    Other conditions: Cardiovascular Event, Parkinson Disease
    View official trial listing →
  • Completed NCT NCT01556165

    Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China

    Not yet reported H. Lundbeck A/S 130 participants 15 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01568034

    A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067

    Not yet reported Bial - Portela C S.A. 10 participants Est. completion 2010-02 3 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01568047

    Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients

    Not yet reported Bial - Portela C S.A. 40 participants Est. completion 2010-06 7 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01568073

    Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon

    Not yet reported Bial - Portela C S.A. 600 participants Est. completion 2013-11 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01577992

    Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy

    Not yet reported University Hospital, Toulouse 42 participants Est. completion 2013-11-30 1 site Stand-alone
    Other conditions: Pain Threshold, Multiple System Atrophy
    View official trial listing →
  • Completed NCT NCT01602549

    A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying

    Not yet reported GlaxoSmithKline 58 participants Est. completion 2014-05 11 sites
    Other conditions: Gastroparesis
    View official trial listing →
  • Completed NCT NCT01617135

    Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes

    Not yet reported Acorda Therapeutics 25 participants Est. completion 2012-12 7 sites Stand-alone
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01620164

    Assessment of Three-dimensional Vision Alteration in Parkinson Disease

    Not yet reported University Hospital, Toulouse 36 participants Est. completion 2014-06 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT01628848

    A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients

    Not yet reported Otsuka Pharmaceutical Co., Ltd. 174 participants Est. completion 2008-04 7 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01628926

    A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients

    Not yet reported Otsuka Pharmaceutical Co., Ltd. 420 participants Est. completion 2011-05 8 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01628965

    A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients

    Not yet reported, Not yet reported Otsuka Pharmaceutical Co., Ltd. 143 participants Est. completion 2010-10 7 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01631825

    A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients

    Not yet reported Otsuka Pharmaceutical Co., Ltd. 321 participants Est. completion 2012-06 8 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01636037

    Antipsychotic Augmentation With L-Dopa

    Not yet reported Centre for Addiction and Mental Health 13 participants Est. completion 2016-01 1 site Stand-alone
    Other conditions: Schizophrenia
    View official trial listing →
  • Completed NCT NCT01646255

    Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients

    Not yet reported UCB Pharma 346 participants Est. completion 2014-10 24 sites
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT01663935

    Vision Response to Dopamine Replacement

    Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2018-04-12 1 site
    Other conditions: Albinism, Oculocutaneous Albinism
    View official trial listing →
  • Completed NCT NCT01683253

    Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa

    Not yet reported Sandoz 150 participants Est. completion 2014-12 5 sites Stand-alone
    Other conditions: Impulse Control Disorder
    View official trial listing →
  • Completed NCT NCT01688089

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy Volunteers

    Not yet reported Orion Corporation, Orion Pharma 67 participants Est. completion 2014-09 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01725802

    A Safety, Tolerability, and Plasma Concentration Study of Levodopa/Carbidopa Subcutaneous Solution (ND0612) in Parkinson's Disease (PD) Patients

    Not yet reported NeuroDerm Ltd. 8 participants Est. completion 2013-02-26 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01736176

    A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease

    Not yet reported AbbVie (prior sponsor, Abbott) 39 participants Est. completion 2015-12 Stand-alone
    Other conditions: Advanced Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01736891

    Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations

    Not yet reported Chongqing Fortune Pharmaceutical Co., Ltd. 268 participants Est. completion 2013-06 8 sites
    Other conditions: Parkinson´s Disease
    View official trial listing →
  • Completed NCT NCT01754129

    Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa

    AbbVie (prior sponsor, Abbott) 148 participants Est. completion 2016-05
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01766258

    Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations

    Not yet reported Orion Corporation, Orion Pharma 117 participants Est. completion 2012-09 Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01767129

    Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients

    Not yet reported Avanir Pharmaceuticals 14 participants Est. completion 2015-02-05 3 sites
    Other conditions: Dyskinesia, Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01770145

    Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)

    Not yet reported MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals 127 participants Est. completion 2014-04 12 sites Stand-alone
    Other conditions: Parkinson's Disease, Motor Symptoms, Akinesia, Hypomobility, Delayed Levodopa Onset
    View official trial listing →
  • Completed NCT NCT01777555

    Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes

    Not yet reported Acorda Therapeutics 89 participants Est. completion 2014-01 22 sites
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT01780467

    Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian Patients

    Not yet reported University Hospital, Clermont-Ferrand 40 participants Est. completion 2015-12 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01840423

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers

    Not yet reported Orion Corporation, Orion Pharma 101 participants Est. completion 2014-12 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT01883505

    A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease Patients

    Not yet reported NeuroDerm Ltd. 30 participants Est. completion 2015-04-26 3 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01920425

    Kinesia HomeView - Home Diary Comparison

    Not yet reported Great Lakes NeuroTechnologies Inc. 2 participants Est. completion 2015-09 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01937078

    Famotidine for Levodopa-induced Dyskinesia in PD

    Not yet reported University Health Network, Toronto 7 participants Est. completion 2014-03 1 site
    Other conditions: Dyskinesia
    View official trial listing →
  • Status unknown NCT NCT01937169

    Targeting Dopamine Therapy in RLS

    Not yet reported Tel-Aviv Sourasky Medical Center 30 participants 1 site Stand-alone
    Other conditions: Restless Legs Syndrome
    View official trial listing →
  • Completed NCT NCT01951105

    Effect of L-dopa In Subacute Back Pain Population

    Not yet reported Northwestern University 72 participants Est. completion 2017-09-25 1 site
    Other conditions: Sub-acute Back Pain
    View official trial listing →
  • Completed NCT NCT01956032

    Duodopa Home Titration Using Telemedicine: Evaluation of Use of Resources

    AbbVie 15 participants Est. completion 2014-11
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01960842

    A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications

    Not yet reported AbbVie 31 participants Est. completion 2015-03 Stand-alone
    Other conditions: Advanced Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01973543

    Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease

    Not yet reported Neurocrine Biosciences 15 participants Est. completion 2020-01-24 2 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT01996878

    Genetic Polymorphism and Parkinson's Disease in Taiwanese

    Changhua Christian Hospital 334 participants Est. completion 2013-10 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02005029

    Erythromycin in Parkinson's Disease

    Not yet reported Virginia Commonwealth University 18 participants Est. completion 2015-06 1 site
    Other conditions: Parkinson's Disease, Levodopa
    View official trial listing →
  • Completed NCT NCT02073773

    Combinational Rehabilitative Therapy and Functional Brain Imaging for Patients Recovering From Motor Stroke

    Not yet reported Singapore General Hospital 9 participants Est. completion 2015-11 1 site Stand-alone
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT02080819

    Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse

    Not yet reported Virginia Commonwealth University 131 participants Est. completion 2017-01-21 1 site Stand-alone
    Other conditions: Cocaine Dependence
    View official trial listing →
  • Completed NCT NCT02082249

    An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications

    Not yet reported AbbVie 30 participants Est. completion 2019-10-31 7 sites
    Other conditions: Advanced Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02096601

    A Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients

    Not yet reported NeuroDerm Ltd. 16 participants Est. completion 2015-03-15 2 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02112812

    Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease

    Not yet reported National University of Malaysia 82 participants Est. completion 2013-04 1 site
    Other conditions: Response to Levodopa, Motor Outcomes, Quality of Life Outcomes
    View official trial listing →
  • Completed NCT NCT02116465

    Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration

    Not yet reported Desitin Arzneimittel GmbH 12 participants Est. completion 2014-03 1 site
    Other conditions: Fasted State
    View official trial listing →
  • Withdrawn NCT NCT02116790

    Efficacy of Co-administration of an NSAID With a Dopamine Agonist In Healthy Subjects

    Not yet reported Northwestern University Est. completion 2015-01
    Other conditions: Acute Pain
    View official trial listing →
  • Completed NCT NCT02125825

    Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration

    Great Lakes NeuroTechnologies Inc. 14 participants Est. completion 2014-12 2 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02136914

    ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)

    Not yet reported Adamas Pharmaceuticals, Inc. 126 participants Est. completion 2015-12 46 sites
    Other conditions: Dyskinesia, Levodopa Induced Dyskinesia (LID), Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02137278

    Stop Vasodepressor Drugs in Reflex Syncope

    Not yet reported Gruppo Italiano Multidisciplinare per lo Studio della Sincope 58 participants Est. completion 2015-12 1 site
    Other conditions: Hypotensive Syncope
    View official trial listing →
  • Terminated NCT NCT02153632

    Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID

    Not yet reported Adamas Pharmaceuticals, Inc. 135 participants Est. completion 2016-05-20 56 sites
    Other conditions: Parkinson's Disease, Levodopa Induced Dyskinesia (LID)
    View official trial listing →
  • Terminated NCT NCT02153645

    Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.

    Not yet reported Adamas Pharmaceuticals, Inc. 87 participants Est. completion 2016-05-20 56 sites
    Other conditions: Parkinson's Disease, Levodopa Induced Dyskinesias (LID)
    View official trial listing →
  • Completed NCT NCT02169414

    Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics

    Not yet reported Bial - Portela C S.A. 74 participants Est. completion 2010-07 1 site Stand-alone
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT02169453

    Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa

    Not yet reported Bial - Portela C S.A. 12 participants Est. completion 2009-01 1 site Stand-alone
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT02169466

    Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide

    Not yet reported Bial - Portela C S.A. 22 participants Est. completion 2009-05 1 site Stand-alone
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT02169479

    Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa

    Not yet reported Bial - Portela C S.A. 16 participants Est. completion 2008-12 1 site Stand-alone
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT02169895

    Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide

    Not yet reported Bial - Portela C S.A. 16 participants Est. completion 2008-11 1 site Stand-alone
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT02170376

    The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics

    Not yet reported Bial - Portela C S.A. 80 participants Est. completion 2012-01 1 site Stand-alone
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT02172573

    Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease

    Not yet reported Boehringer Ingelheim 315 participants
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02177357

    Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients

    Not yet reported Boehringer Ingelheim 150 participants
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02200887

    Sleep Homeostasis in Parkinson's Disease

    Salvatore Galati 48 participants Est. completion 2015-06 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02202551

    Open-Label Safety Study of ADS-5102 in PD Patients With LID

    Not yet reported Adamas Pharmaceuticals, Inc. 223 participants Est. completion 2018-02 87 sites
    Other conditions: Dyskinesia, Levodopa Induced Dyskinesia (LID), Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT02224664

    Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease

    Not yet reported Pfizer 50 participants Est. completion 2016-03 17 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02227355

    Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease

    UCB Biopharma S.P.R.L. 195 participants Est. completion 2016-06 42 sites
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02239978

    Effect of Levodopa on Postural Motor Learning in Parkinson Disease

    VA Office of Research and Development 42 participants Est. completion 2016-09 3 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02240030

    Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

    Not yet reported Acorda Therapeutics 351 participants Est. completion 2016-12 74 sites Stand-alone
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02242487

    Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes

    Not yet reported Acorda Therapeutics 325 participants Est. completion 2018-05 74 sites Stand-alone
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02271503

    A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease

    Not yet reported Impax Laboratories, LLC 26 participants Est. completion 2016-08 11 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02274766

    Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia

    Not yet reported Adamas Pharmaceuticals, Inc. 77 participants Est. completion 2016-03-10 51 sites
    Other conditions: Dyskinesia, Levodopa-Induced Dyskinesia (LID), Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT02289729

    Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease

    AbbVie 62 participants Est. completion 2016-11
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02312232

    Pharmacokinetic Study in Healthy Males

    Not yet reported Orion Corporation, Orion Pharma 20 participants Est. completion 2015-02 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02337725

    A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients

    Not yet reported Takeda 244 participants Est. completion 2016-09-15 55 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02337738

    A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants

    Not yet reported, Not yet reported Takeda 404 participants Est. completion 2016-09-17 57 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02337764

    A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants

    Not yet reported Takeda 222 participants Est. completion 2016-09-29 24 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Active, not recruiting NCT NCT02339064

    Infusion of Apomorphine: Long-term Safety Study

    Not yet reported MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals 99 participants Est. completion 2025-12 18 sites
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Withdrawn NCT NCT02346630

    Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation

    Not yet reported Ross D. Zafonte, MD Est. completion 2017-03 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02347059

    L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease

    Not yet reported University of Toronto 40 participants Est. completion 2016-08 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02347254

    ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease

    Not yet reported InSightec 2 participants Est. completion 2017-12 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02352363

    Randomized Safety Study of CVT-301 Compared to an Observational Control Group

    Not yet reported Acorda Therapeutics 408 participants Est. completion 2017-05 76 sites Stand-alone
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02381444

    Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy

    AbbVie 136 participants Est. completion 2020-01-07 27 sites
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT02384512

    Azilect® In Wearing-Off (AIWO)

    Teva Pharma GmbH 261 participants Est. completion 2015-01 140 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02386475

    Effect of Serotonin and Levodopa in Ischemic Stroke

    Not yet reported Hospital de Granollers 39 participants Est. completion 2019-10-31 1 site
    Cardiovascular disease
    View official trial listing →
  • Status unknown NCT NCT02439125

    A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients

    Not yet reported Amarantus BioScience Holdings, Inc. 60 participants Est. completion 2017-12 1 site
    Other conditions: Parkinson's Disease, Dyskinesia
    View official trial listing →
  • Completed NCT NCT02439203

    Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia

    Not yet reported Bukwang Pharmaceutical 30 participants Est. completion 2016-01 1 site
    Other conditions: Parkinson's Disease, Levodopa Induced Dyskinesia (LID)
    View official trial listing →
  • Completed NCT NCT02448914

    A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients

    Not yet reported LobSor Pharmaceuticals AB 11 participants Est. completion 2015-07 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT02452606

    Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease

    Not yet reported Asan Medical Center 100 participants Est. completion 2017-05 1 site
    Other conditions: Parkinson Disease, Sleep Disorders
    View official trial listing →
  • Terminated NCT NCT02453386

    Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients

    Not yet reported Biotie Therapies Inc. 449 participants Est. completion 2018-01-12 71 sites
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02469090

    Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease

    Not yet reported Sumitomo Pharma America, Inc. 141 participants Est. completion 2017-12-11 33 sites
    Other conditions: Parkinson Disease, Off Episodes
    View official trial listing →
  • Completed NCT NCT02480803

    INfusion VErsus STimulation in Parkinson's Disease

    Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 51 participants Est. completion 2024-01-26 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02485600

    Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients

    AbbVie 88 participants Est. completion 2020-02-26 13 sites
    Other conditions: Parkinson Disease (PD)
    View official trial listing →
  • Completed NCT NCT02486432

    A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)

    Not yet reported NeuroDerm Ltd. 6 participants Est. completion 2015-04 Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02513485

    Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa

    Not yet reported Emory University 57 participants Est. completion 2020-08-01 1 site
    Other conditions: Depression
    View official trial listing →
  • Completed NCT NCT02542696

    Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease

    Not yet reported Sumitomo Pharma America, Inc. 496 participants Est. completion 2022-11-08 70 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Terminated NCT NCT02549573

    Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®

    Not yet reported MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals 13 participants Est. completion 2016-12 12 sites
    Other conditions: Parkinson's Disease, Motor Symptoms
    View official trial listing →
  • Completed NCT NCT02554734

    Pharmacokinetic Study in Healthy Volunteers

    Not yet reported Orion Corporation, Orion Pharma 15 participants Est. completion 2015-11 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02560389

    Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)

    Not yet reported University of Wisconsin, Madison 103 participants Est. completion 2018-05-01 1 site
    Other conditions: Stress Disorder, Post Traumatic
    View official trial listing →
  • Completed NCT NCT02577523

    A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's Disease

    Not yet reported NeuroDerm Ltd. 38 participants Est. completion 2017-01-31 11 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT02578849

    Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia

    Aarhus University Hospital 45 participants Est. completion 2016-01 1 site
    Other conditions: Parkinson´s Disease
    View official trial listing →
  • Terminated NCT NCT02589340

    Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia

    Not yet reported Oregon Health and Science University 6 participants Est. completion 2021-02-23 1 site
    Other conditions: Parkinson's Disease, Dyskinesias, Movement Disorders
    View official trial listing →
  • Completed NCT NCT02601586

    Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease

    Not yet reported, Not yet reported University Hospital, Toulouse 67 participants Est. completion 2020-11 18 sites Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02604914

    A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects

    Not yet reported NeuroDerm Ltd. 36 participants Est. completion 2016-06-30 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT02605434

    A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients

    Not yet reported Intec Pharma Ltd. 420 participants Est. completion 2019-12 97 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02611713

    Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease

    AbbVie 213 participants Est. completion 2020-12-24 54 sites
    Other conditions: Advanced Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT02615873

    A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004

    Not yet reported Intec Pharma Ltd. 460 participants Est. completion 2019-12 85 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02617017

    Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease

    Not yet reported Assistance Publique - Hôpitaux de Paris 99 participants Est. completion 2023-03-23 1 site
    Other conditions: Parkinson
    View official trial listing →
  • Completed NCT NCT02633007

    A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma

    Not yet reported Acorda Therapeutics 25 participants Est. completion 2016-05 3 sites Stand-alone
    Other conditions: Asthma
    View official trial listing →
  • Completed NCT NCT02633839

    A Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking Adults

    Not yet reported Acorda Therapeutics 60 participants Est. completion 2016-06 2 sites Stand-alone
    Other conditions: Smoking
    View official trial listing →
  • Completed NCT NCT02641054

    Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease

    Not yet reported CleveXel Pharma 21 participants Est. completion 2017-07 1 site Stand-alone
    Other conditions: Idiopathic Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02657681

    Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)

    Not yet reported Fundación de investigación HM 50 participants Est. completion 2018-09 1 site
    Other conditions: Dyskinesia, Medication-Induced, Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT02668497

    Kinematic-based BoNT-A Bilateral Upper Limb PD Therapy

    Not yet reported Western University, Canada 50 participants Est. completion 2020-12 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02680977

    Mucuna Pruriens Therapy in Parkinson's Disease

    Not yet reported ASST Gaetano Pini-CTO 18 participants Est. completion 2016-09 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT02696512

    A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness

    Not yet reported, Not yet reported International Brain Research Foundation 30 participants Est. completion 2017-04 1 site Stand-alone
    Other conditions: Brain Injury
    View official trial listing →
  • Completed NCT NCT02701803

    Parkinson's KinetiGraph, PKG in Patients With Deep Brain Stimulation and Continuous Levodopa Infusion Therapy

    Hospital District of Helsinki and Uusimaa 8 participants Est. completion 2018-06 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02706977

    The Effect of Dopamine on Diabetic Retinopathy

    Not yet reported Emory University 60 participants Est. completion 2019-08-15 1 site Stand-alone
    Other conditions: Diabetes
    View official trial listing →
  • Active, not recruiting NCT NCT02726386

    A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease

    Not yet reported NeuroDerm Ltd. 214 participants Est. completion 2027-02 57 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02741947

    Levodopa Benserazide Generic Formulation Versus the Originator

    Not yet reported IRCCS San Raffaele Roma 44 participants Est. completion 2015-12 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02744391

    A Study of L-DOPA for Depression and Slowing in Older Adults

    Not yet reported New York State Psychiatric Institute 47 participants Est. completion 2018-11-30 1 site Stand-alone
    Other conditions: Major Depressive Disorder, Dysthymia, Depression Not Otherwise Specified, Decreased Processing Speed, Decreased Gait Speed
    View official trial listing →
  • Completed NCT NCT02763137

    Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients

    Not yet reported IRCCS San Raffaele Roma 18 participants Est. completion 2015-10 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02763839

    Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)

    Not yet reported Bial - Portela C S.A. 19 participants Est. completion 2001-07 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02763852

    Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)

    Not yet reported Bial - Portela C S.A. 18 participants Est. completion 2001-07 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02764125

    Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)

    Not yet reported Orion Corporation, Orion Pharma 84 participants Est. completion 2018-03-27 4 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02769793

    Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON

    Not yet reported Seoul National University Hospital 40 participants Est. completion 2018-12 2 sites Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02774564

    Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa

    Not yet reported Bial - Portela C S.A. 16 participants Est. completion 2005-11 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02778594

    Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide

    Not yet reported Bial - Portela C S.A. 17 participants Est. completion 2005-11 1 site Stand-alone
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Withdrawn NCT NCT02782481

    A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations

    Not yet reported NeuroDerm Ltd. Est. completion 2018-10-15 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT02785978

    Pilot Study to Evaluate ActiMyo Measured Activity in Parkinson Disease Patients & Healthy Volunteers

    Not yet reported Institut de Myologie, France 30 participants Est. completion 2017-07 3 sites Stand-alone
    Other conditions: Parkinson Disease, Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT02799381

    A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)

    Not yet reported AbbVie 63 participants Est. completion 2019-09-19 28 sites Stand-alone
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT02807675

    A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)

    Not yet reported Acorda Therapeutics 36 participants Est. completion 2016-11 11 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT02812147

    Effect of L-Dihydoxyphenylserine on Locomotion, Postural Stability, and Fall Risk Reduction in Parkinson Disease

    Not yet reported St. Joseph's Hospital and Medical Center, Phoenix 20 participants Est. completion 2019-06 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02812394

    A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets

    Not yet reported Acorda Therapeutics 24 participants Est. completion 2016-09 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT02834507

    Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients

    Not yet reported Bial - Portela C S.A. 19 participants Est. completion 2005-11 Stand-alone
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Status unknown NCT NCT02837640

    Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa

    Not yet reported Beirut Eye Specialist Hospital 50 participants Est. completion 2021-06 1 site Stand-alone
    Obstructive sleep apnea
    View official trial listing →
  • Completed NCT NCT02847442

    Efficacy and Safety of Opicapone in Clinical Practice

    Not yet reported Bial - Portela C S.A. 518 participants Est. completion 2018-07-04 1 site Stand-alone
    Other conditions: Parkinson's Disease With Wearing-off Motor Fluctuations
    View official trial listing →
  • Terminated NCT NCT02863640

    Evaluation of the Protective Role of the L-DOPA Against Age Related Macular Degeneration in Parkinson's Patients

    Fondation Ophtalmologique Adolphe de Rothschild 13 participants Est. completion 2017-12-18 1 site
    Other conditions: Macular Degeneration, Senile
    View official trial listing →
  • Withdrawn NCT NCT02873351

    A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration

    Not yet reported Snyder, Robert W., M.D., Ph.D., P.C. Est. completion 2020-12 1 site Stand-alone
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Terminated NCT NCT02896816

    EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease

    Not yet reported Spaulding Rehabilitation Hospital 17 participants Est. completion 2021-05-25 1 site Stand-alone
    Other conditions: Parkinson
    View official trial listing →
  • Completed NCT NCT02952014

    Assessment of a Pre-Workout Dietary Supplement

    Not yet reported Texas A&M University 31 participants Est. completion 2014-05 1 site
    Other conditions: Dietary Modification
    View official trial listing →
  • Active, not recruiting NCT NCT02994719

    Gait Analysis in Neurological Disease

    Beth Israel Deaconess Medical Center 120 participants Est. completion 2027-07-07 1 site
    Other conditions: Parkinson's Disease, Parkinsonian Disorders, Atypical Parkinson Disease, Progressive Supranuclear Palsy, Multiple System Atrophy, Corticobasal Degeneration, Gait, Frontal, Huntington Disease, Ataxia, Spinocerebellar
    View official trial listing →
  • Completed NCT NCT03000569

    A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease

    Not yet reported Biogen 29 participants Est. completion 2017-09-11 11 sites Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03007888

    A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease

    Not yet reported Impax Laboratories, LLC 28 participants Est. completion 2017-08-01 11 sites Stand-alone
    Other conditions: Advanced Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT03022318

    Carbidopa-levodopa in Neovascular AMD

    Not yet reported Snyder, Robert W., M.D., Ph.D., P.C. 20 participants Est. completion 2020-05-04 1 site Stand-alone
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT03023059

    Dose Ranging Study of Carbidopa-levodopa

    Not yet reported Snyder, Robert W., M.D., Ph.D., P.C. 35 participants Est. completion 2020-05-04 1 site Stand-alone
    Other conditions: Age-related Macular Degeneration
    View official trial listing →
  • Terminated NCT NCT03051607

    Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.

    Not yet reported Biotie Therapies Inc. 66 participants Est. completion 2018-01-16 35 sites
    Other conditions: Idiopathic Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03055936

    Dose-finding Pharmacokinetic Study in Healthy Males

    Not yet reported Orion Corporation, Orion Pharma 56 participants Est. completion 2017-06-09 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT03065192

    Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease

    Not yet reported Neurocrine Biosciences 16 participants Est. completion 2021-08-10 4 sites
    Other conditions: Idiopathic Parkinson's Disease, Parkinson's Disease, Basal Ganglia Disease, Brain Diseases, Central Nervous System Diseases, Movement Disorders, Nervous System Diseases, Neurodegenerative Diseases, Parkinsonian Disorders
    View official trial listing →
  • Completed NCT NCT03091543

    Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics

    Not yet reported Bial - Portela C S.A. 20 participants Est. completion 2004-07-23 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03091868

    Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics

    Not yet reported Bial - Portela C S.A. 80 participants Est. completion 2005-02-28 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03094156

    Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics

    Not yet reported Bial - Portela C S.A. 39 participants Est. completion 2006-07-11 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03097211

    Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg

    Not yet reported Bial - Portela C S.A. 38 participants Est. completion 2006-10-20 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03103399

    Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon

    Not yet reported Bial - Portela C S.A. 254 participants Est. completion 2007-09-21 Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03111485

    Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease

    Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 36 participants Est. completion 2022-10-28 1 site Stand-alone
    Obstructive sleep apnea Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT03119636

    Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's Disease

    Not yet reported, Not yet reported Chinese Academy of Sciences 50 participants Est. completion 2020-12 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT03129451

    The Microbiome in Parkinson's Disease

    Corewell Health West 23 participants Est. completion 2021-01-07 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03140956

    Pharmacokinetic of Levodopa Study in Healthy Males

    Not yet reported Orion Corporation, Orion Pharma 20 participants Est. completion 2017-08-03 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03151460

    Dopaminergic Modulation of Declarative Memory

    Not yet reported I.R.C.C.S. Fondazione Santa Lucia 40 participants Est. completion 2016-04 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT03162874

    Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients

    Not yet reported Prexton Therapeutics 157 participants Est. completion 2020-03-02 45 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03197493

    Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)

    Not yet reported Snyder, Robert W., M.D., Ph.D., P.C. 35 participants Est. completion 2020-07-09 1 site Stand-alone
    Other conditions: Macula; Degeneration, Retina
    View official trial listing →
  • Completed NCT NCT03205956

    Measuring Parkinson's Disease Progression

    Not yet reported Kevin J. Black, MD 31 participants Est. completion 2019-10-19 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT03235037

    Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome

    Not yet reported Bennett Lavenstein 10 participants Est. completion 2019-02-01
    Other conditions: Angelman Syndrome
    View official trial listing →
  • Status unknown NCT NCT03243552

    Proof of Mechanism Study for the Treatment of Social Anhedonia in ASD

    Not yet reported University of California, Los Angeles 56 participants Est. completion 2023-12 1 site
    Other conditions: ASD
    View official trial listing →
  • Terminated NCT NCT03250117

    Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole

    Not yet reported, Not yet reported Titan Pharmaceuticals 6 participants Est. completion 2018-05-22 3 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Withdrawn NCT NCT03331848

    Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED)

    Not yet reported Prexton Therapeutics Est. completion 2019-02-01
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03333369

    Exceptional Experiences (EE), Salience & Dopaminergic Neurotransmission

    Not yet reported University of Zurich 65 participants Est. completion 2015-08-13 1 site
    Other conditions: Healthy, Schizotypal Personality
    View official trial listing →
  • Completed NCT NCT03336307

    Predictors of Gait Improvement in Patients With Parkinson's Disease After Rehabilitation

    University of Roma La Sapienza 36 participants Est. completion 2017-07 1 site
    Other conditions: Parkinson Disease, Movement Disorders
    View official trial listing →
  • Completed NCT NCT03354455

    Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease

    Not yet reported Danish Research Centre for Magnetic Resonance 20 participants Est. completion 2018-09-16 1 site
    Other conditions: Dyskinesia, Drug-Induced, Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03368170

    Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia

    Not yet reported Integrative Research Laboratories AB 75 participants Est. completion 2019-06-12 20 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03374917

    A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment

    Not yet reported AbbVie 20 participants Est. completion 2019-03-04 12 sites
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT03391882

    A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)

    Not yet reported Sumitomo Pharma America, Inc. 113 participants Est. completion 2021-08-11 31 sites
    Other conditions: Motor OFF Episodes Associated With Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT03415984

    Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson's Patients and Assesment of the Role of L-DOPA

    Fondation Ophtalmologique Adolphe de Rothschild 133 participants Est. completion 2019-01-15 1 site
    Other conditions: Parkinson Disease, Age Related Macular Degeneration
    View official trial listing →
  • Completed NCT NCT03419806

    Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease

    Not yet reported Vastra Gotaland Region 25 participants Est. completion 2020-04-20 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Terminated NCT NCT03451500

    Carbidopa-Levodopa in Dry AMD With Geographic Atrophy

    Not yet reported Snyder, Robert W., M.D., Ph.D., P.C. 7 participants Est. completion 2019-10-31 1 site Stand-alone
    Other conditions: Age Related Macular Degeneration
    View official trial listing →
  • Withdrawn NCT NCT03462043

    A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension

    Not yet reported NeuroDerm Ltd. Est. completion 2018-12-30 1 site
    Other conditions: Parkinson
    View official trial listing →
  • Completed NCT NCT03496870

    A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.

    Not yet reported Neurocrine Biosciences 16 participants Est. completion 2018-07-02 3 sites Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03517059

    Study of Dysarthria, and the Appearance of Non-dopaminergic Signs in Idiopathic PARKinson's Disease

    University Hospital, Lille 29 participants Est. completion 2018-11-12 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03521635

    The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa

    Not yet reported Boehringer Ingelheim 98 participants Est. completion 2020-01-07 12 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03531060

    A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

    Not yet reported, Not yet reported Integrative Research Laboratories AB 15 participants Est. completion 2017-04-12
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03541356

    Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal

    Not yet reported Impel Pharmaceuticals 32 participants Est. completion 2019-06-11 5 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT03562494

    VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)

    Not yet reported Neurocrine Biosciences 14 participants Est. completion 2024-10-30 11 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT03576638

    Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients

    Not yet reported Intec Pharma Ltd. 12 participants Est. completion 2019-01 Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03581305

    PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects

    Not yet reported National Institutes of Health Clinical Center (CC) 46 participants Est. completion 2022-04-06 1 site
    Other conditions: Depression, HIV Infections, HIV-Associated Cognitive Motor Complex
    View official trial listing →
  • Completed NCT NCT03591757

    Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)

    Not yet reported Boston University 10 participants Est. completion 2019-04-26 1 site Stand-alone
    Other conditions: Transthyretin Amyloidosis, Amyloidosis, Leptomeningeal, Transthyretin-Related
    View official trial listing →
  • Completed NCT NCT03599726

    Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil

    Not yet reported Oregon Health and Science University 20 participants Est. completion 2019-07-30 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT03602924

    Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion

    Hospital Universitari Vall d'Hebron Research Institute 40 participants Est. completion 2018-12-31 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT03648671

    Pain in Parkinson's Disease With Motor Fluctuations.

    Universita di Verona 48 participants Est. completion 2019-11-30 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03648905

    Clinical Laboratory Evaluation of Chronic Autonomic Failure

    National Institute of Neurological Disorders and Stroke (NINDS) 89 participants Est. completion 2026-07-15 1 site
    Other conditions: Parkinson's Disease, Multiple System Atrophy, Autonomic Failure
    View official trial listing →
  • Completed NCT NCT03665454

    PF 06412562 in Subjects With Advanced Stage Parkinson's Disease

    Not yet reported Milton S. Hershey Medical Center 8 participants Est. completion 2019-04-21 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03665493

    Dopamine Effect on Inhibitory Control

    Not yet reported Giovanni Mirabella 90 participants Est. completion 2023-11-10 1 site Stand-alone
    Other conditions: Idiopathic Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT03670953

    A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations

    Not yet reported Impax Laboratories, LLC 630 participants Est. completion 2021-06-15 108 sites
    Other conditions: Parkinson's Disease (Disorder)
    View official trial listing →
  • Completed NCT NCT03703570

    A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations

    Not yet reported Kyowa Kirin Co., Ltd. 502 participants Est. completion 2020-04-15 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT03733496

    Observational, Long-term Extension Study for Participants of Prior VY-AADC01 Studies

    Neurocrine Biosciences 14 participants Est. completion 2023-07-18 3 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Active, not recruiting NCT NCT03735901

    Enhancement of Stroke Rehabilitation With Levodopa

    Not yet reported University Hospital, Basel, Switzerland 610 participants Est. completion 2029-06-30 24 sites
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT03754062

    Pharmacological Modulation of Belief Salience

    Not yet reported King's College London 30 participants Est. completion 2019-09-01 1 site
    Other conditions: Haloperidol, Placebo, L-DOPA
    View official trial listing →
  • Completed NCT NCT03761004

    WD-1603 PK Study in Healthy Volunteers

    Not yet reported Hong Kong WD Pharmaceutical Co., Limited 8 participants Est. completion 2019-09-05 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Terminated NCT NCT03761030

    L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults

    Not yet reported New York State Psychiatric Institute 51 participants Est. completion 2021-09-08 1 site Stand-alone
    Other conditions: Major Depressive Disorder, Dysthymia, Depression
    View official trial listing →
  • Completed NCT NCT03778294

    18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy

    Not yet reported Mayo Clinic 43 participants Est. completion 2023-11-26 2 sites
    Other conditions: Glioblastoma, Malignant Glioma
    View official trial listing →
  • Completed NCT NCT03781167

    A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)

    Not yet reported AbbVie 244 participants Est. completion 2022-08-17 65 sites
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Status unknown NCT NCT03793491

    Personality, as a Predictive Factor of Therapeutic Response on Quality of Life After Continuous Perfusion of Dopaminergic Drugs, in Parkinson's Disease

    University Hospital, Toulouse 60 participants Est. completion 2021-06-18 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03841604

    Effect of Safinamide on Parkinson's Disease Related Chronic Pain

    Not yet reported Zambon SpA 94 participants Est. completion 2021-05-03 45 sites
    Other conditions: Idiopathic Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03872557

    Modulating Glucose Tolerance With Dietary Tyrosine

    Not yet reported Columbia University 10 participants Est. completion 2020-01-24 1 site
    Other conditions: Glucose Tolerance
    View official trial listing →
  • Completed NCT NCT03881371

    A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa

    Not yet reported Zambon SpA 307 participants Est. completion 2021-08-20 31 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03887884

    Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)

    Not yet reported Acorda Therapeutics 23 participants Est. completion 2019-06-28 5 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT03891095

    Oxytocin and Dopamine's Effect on Vicarious Optimism

    Not yet reported Beijing Normal University 156 participants Est. completion 2019-01-16 1 site
    Other conditions: Oxytocin Group, L-DOPA Group, Placebo Group
    View official trial listing →
  • Completed NCT NCT03918616

    P2X7 Receptor, Inflammation and Neurodegenerative Diseases

    University of Pisa 50 participants Est. completion 2019-03-30 1 site
    Other conditions: Neuro-Degenerative Disease
    View official trial listing →
  • Terminated NCT NCT03922711

    A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease

    Not yet reported Prilenia 23 participants Est. completion 2020-07-22 33 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03929068

    Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis

    Not yet reported Washington University School of Medicine 15 participants Est. completion 2022-07-08 1 site
    Other conditions: Amyotrophic Lateral Sclerosis, Motor Neuron Disease
    View official trial listing →
  • Completed NCT NCT03944785

    Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)

    Supernus Pharmaceuticals, Inc. 164 participants Est. completion 2020-01-10 30 sites
    Other conditions: Idiopathic Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03959540

    Safety and Effectiveness of Opicapone Plus Standard of Care in Elderly Patients With Parkinson's Disease

    Bial - Portela C S.A. 39 participants Est. completion 2021-05-11 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT03982953

    Predicting Cognition After DBS for Parkinson's Disease

    Charite University, Berlin, Germany 60 participants Est. completion 2022-08-10 1 site
    Other conditions: Parkinson's Disease, Deep Brain Stimulation, Postoperativeneurocognitive Deficit, Postoperative Delirium
    View official trial listing →
  • Withdrawn NCT NCT03987750

    Safinamide for Levodopa-induced Dyskinesia (PD-LID)

    Not yet reported Zambon SpA Est. completion 2021-05
    Other conditions: Dyskinesia, Drug-Induced, Parkinson Disease
    View official trial listing →
  • Completed NCT NCT03994328

    An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD

    Zambon SpA 1235 participants Est. completion 2023-12-31 3 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Suspended NCT NCT04000919

    Effects of 5HTP and LDOPA on CNS Excitability After SCI

    Not yet reported, Not yet reported Jessica M D'Amico 30 participants Est. completion 2023-12-30 1 site
    Other conditions: Spinal Cord Injuries
    View official trial listing →
  • Active, not recruiting NCT NCT04006210

    Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations

    Not yet reported NeuroDerm Ltd. 381 participants Est. completion 2027-02 103 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT04052776

    Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES

    Not yet reported Centre Hospitalier Universitaire Vaudois 3 participants Est. completion 2023-10-04 1 site
    Other conditions: Spinal Cord Injuries, Drug Effect
    View official trial listing →
  • Status unknown NCT NCT04054960

    A Trial of tPCS on Parkinson's Disease OFF State

    Not yet reported Western University, Canada 15 participants Est. completion 2021-10 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04064294

    Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors

    VA Office of Research and Development 93 participants Est. completion 2024-03-31 3 sites
    Other conditions: Parkinson Disease, Dyskinesia, Drug-Induced
    View official trial listing →
  • Withdrawn NCT NCT04082715

    Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity

    Not yet reported Second Affiliated Hospital of Wenzhou Medical University Est. completion 2023-12 1 site Stand-alone
    Other conditions: Chronic Back Pain
    View official trial listing →
  • Status unknown NCT NCT04147949

    AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia

    Not yet reported VistaGen Therapeutics, Inc. 20 participants Est. completion 2024-04
    Other conditions: Parkinson Disease, Dyskinesia, Medication-Induced, L-Dopa Causing Adverse Effects in Therapeutic Use
    View official trial listing →
  • Status unknown NCT NCT04173832

    Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine

    Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100 participants Est. completion 2021-12-31 1 site
    Other conditions: L-DOPA-Induced Dyskinesia
    View official trial listing →
  • Status unknown NCT NCT04173845

    Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia

    Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 150 participants Est. completion 2021-12-31 1 site
    Other conditions: Levodopa-Induced Dyskinesia
    View official trial listing →
  • Completed NCT NCT04184791

    Computational Modeling of 60 Hz Subthalamic Nucleus Deep Brain Stimulation for Gait Disorder in Parkinson's Disease

    Not yet reported Northwell Health 24 participants Est. completion 2022-08-31 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04218526

    Deep Brain Stimulation of the Cuneiform Nucleus for Levodopa-resistant Freezing of Gait in Parkinson's Disease

    Not yet reported Jonathan Jagid 5 participants Est. completion 2024-09-12 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04236921

    Bioequivalence Bewteen DopaSnap® (Cabidopa/Levopdoap 25/100 mg Tablet) and Carbidopa/Levodopa 25/100 mg Tablet (Actavis)

    Not yet reported Riverside Pharmacueticals Corporation 57 participants Est. completion 2019-12-01 1 site
    Other conditions: Other
    View official trial listing →
  • Suspended NCT NCT04244058

    Changes in Glutamatergic Neurotransmission of Severe TBI Patients

    Not yet reported Weill Medical College of Cornell University 30 participants Est. completion 2023-06-30 1 site
    Other conditions: Disorder of Consciousness, Traumatic Brain Injury
    View official trial listing →
  • Completed NCT NCT04308135

    Differences Between Patients With Vascular Parkinsonism and Parkinson's Disease

    Ain Shams University 104 participants Est. completion 2022-04-01 1 site
    Other conditions: Vascular Parkinsonism, Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT04332276

    Dopaminergic restauratIon by intraVEntriculaire Administration

    Not yet reported, Not yet reported University Hospital, Lille 12 participants Est. completion 2024-05-06 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT04357483

    Effect of Thrombin-containing Collagen-based Hemostatic Matrix

    Not yet reported Asan Medical Center 60 participants Est. completion 2020-09-30 1 site
    Other conditions: Pancreatic Tumor
    View official trial listing →
  • Completed NCT NCT04379050

    Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease

    Not yet reported AbbVie 130 participants Est. completion 2026-04-17 51 sites
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT04380142

    Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease

    Not yet reported AbbVie 174 participants Est. completion 2021-09-29 76 sites Stand-alone
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT04435431

    A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia

    Not yet reported Integrative Research Laboratories AB 155 participants Est. completion 2022-12-09 44 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT04441697

    Sleepiness in Parkinson's Patients With Continuous Dopaminergic Delivery Device or Deep Brain Stimulation

    Central Hospital, Nancy, France 30 participants Est. completion 2023-06 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04455074

    Validation of the Neuropsychiatric Fluctuations Scale (EFN-VALID))

    Not yet reported University Hospital, Grenoble 130 participants Est. completion 2023-03-23 6 sites
    Other conditions: Parkinson Disease, Fluctuating Mood Symptoms
    View official trial listing →
  • Completed NCT NCT04469959

    Dopaminergic Dysfunction in Late-Life Depression

    Not yet reported Vanderbilt University Medical Center 79 participants Est. completion 2026-04-29 2 sites Stand-alone
    Other conditions: Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant, Levodopa, Gait Impairment
    View official trial listing →
  • Terminated NCT NCT04493320

    1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)

    Not yet reported New York State Psychiatric Institute 5 participants Est. completion 2021-10-27 1 site Stand-alone
    Other conditions: Depression, Cognitive Impairment, Gait Impairment
    View official trial listing →
  • Completed NCT NCT04500106

    Study to Assess Participant/Caregiver/Investigator Satisfaction of Video-Assisted Telenursing in Adult Participants With Parkinson's Disease Treated With Levodopa-Carbidopa Intestinal Gel

    AbbVie 41 participants Est. completion 2021-10-14 13 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT04513340

    WD-1603 PK Study Under Fasting and Fed Conditions in Healthy Subjects

    Not yet reported Hong Kong WD Pharmaceutical Co., Limited 8 participants Est. completion 2021-02-13 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04542499

    Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)

    Not yet reported AbbVie 507 participants Est. completion 2024-02-15 146 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT04553978

    A Single Oral Dose, Crossover Comparative PK Study of WD-1603 in Healthy Subjects Under Fasting Conditions

    Not yet reported Hong Kong WD Pharmaceutical Co., Limited 8 participants Est. completion 2021-03-18 Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT04590612

    Improving Quality of Life in Early Parkinson's Disease

    Not yet reported Western University, Canada 30 participants Est. completion 2022-01
    Other conditions: Parkinson Disease, Depression
    View official trial listing →
  • Status unknown NCT NCT04591535

    PK Study of WD-1603 in Healthy Subjects

    Not yet reported Hong Kong WD Pharmaceutical Co., Limited 8 participants Est. completion 2021-03-28 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT04620980

    Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease

    Neuromed IRCCS 600 participants Est. completion 2024-05-17 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Terminated NCT NCT04650217

    Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing

    Not yet reported New York State Psychiatric Institute 1 participants Est. completion 2021-12-31 1 site
    Other conditions: Depressive Disorder
    View official trial listing →
  • Completed NCT NCT04723147

    DTA (Dopaminergic Therapy for Anhedonia) Study

    Not yet reported Emory University 19 participants Est. completion 2023-10-11 1 site Stand-alone
    Other conditions: Depression, Anhedonia
    View official trial listing →
  • Completed NCT NCT04724109

    A Study of Equfina® on the Incidences of Adverse Drug Reactions in Participants With Parkinson's Disease (Including Participants With Hepatic Impairment)

    Eisai Co., Ltd. 1088 participants Est. completion 2022-10-13 2 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Withdrawn NCT NCT04742348

    Research on Translational Outcomes of Alcohol (Project RETRO)

    Not yet reported University of Washington Est. completion 2023-08 Stand-alone
    Alcohol use disorder
    View official trial listing →
  • Completed NCT NCT04750226

    Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease

    Not yet reported AbbVie 118 participants Est. completion 2026-04-27 52 sites
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT04778176

    Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients

    Not yet reported SynAgile Corporation 17 participants Est. completion 2022-08-02 5 sites Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT04787965

    Opicapone Treatment Initiation Open-Label Study

    Neurocrine Biosciences 239 participants Est. completion 2022-08-04 6 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04821687

    A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD

    Not yet reported SK Chemicals Co., Ltd. 169 participants Est. completion 2022-08-18 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04821830

    Vigor and the LDR in Parkinson Disease

    Not yet reported University of Michigan 19 participants Est. completion 2024-04-25 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Suspended NCT NCT04912115

    Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia

    Not yet reported PharmaTher Inc. 30 participants Est. completion 2024-03-30 7 sites
    Other conditions: Dyskinesias, Movement Disorders, Central Nervous System Diseases, Nervous System Diseases, Neurologic Manifestations
    View official trial listing →
  • Status unknown NCT NCT04952194

    Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease

    Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 180 participants Est. completion 2023-12-31 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04956939

    Levodopa Response and Gut Microbiome in Patients With Parkinson's Disease

    Rush University Medical Center 38 participants Est. completion 2021-03-31 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04978597

    Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)

    Not yet reported Bial - Portela C S.A. 410 participants Est. completion 2024-01-26 1 site
    Other conditions: Parkinson
    View official trial listing →
  • Completed NCT NCT04986982

    OpiCapone Effect on Motor Fluctuations and pAiN

    Not yet reported Bial - Portela C S.A. 144 participants Est. completion 2024-02-16 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04986995

    OpicApone Sleep dISorder

    Not yet reported Bial - Portela C S.A. 22 participants Est. completion 2023-03-29 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT04990284

    eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.

    Not yet reported Bial - Portela C S.A. 106 participants Est. completion 2023-04-04 25 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05001217

    Chinese Herbal Medicine Treatment as Adjunct Therapy for Parkinson's Disease

    Not yet reported, Not yet reported Hong Kong Baptist University 160 participants Est. completion 2024-01-31 2 sites Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05036473

    A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease

    Not yet reported Shanghai WD Pharmaceutical Co., Ltd. 40 participants Est. completion 2022-12-28 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05043103

    Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease

    Britannia Pharmaceuticals Ltd. 312 participants Est. completion 2026-10-07 57 sites
    Other conditions: Advanced Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05083260

    NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa

    Not yet reported, Not yet reported BioVie Inc. 46 participants Est. completion 2023-01-04 16 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Withdrawn NCT NCT05087914

    Novel Non-opioid Post-surgical Pain Treatment in Females

    Not yet reported Northwestern University Est. completion 2024-01-30 1 site Stand-alone
    Other conditions: Acute Pain, Bunionectomy, Toe Fusion
    View official trial listing →
  • Completed NCT NCT05094050

    Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease

    Not yet reported AbbVie 16 participants Est. completion 2023-03-17 10 sites
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Terminated NCT NCT05116813

    Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy

    Not yet reported, Not yet reported Addex Pharma S.A. 17 participants Est. completion 2022-08-15 7 sites
    Other conditions: Parkinson Disease, Dyskinesia, Drug-Induced, Dyskinesias
    View official trial listing →
  • Completed NCT NCT05119075

    Psychological Effects of Levodopa in Parkinson's Disease

    Not yet reported Insel Gruppe AG, University Hospital Bern 23 participants Est. completion 2024-03-31 4 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05128175

    Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and Fed Conditions

    Not yet reported Shanghai WD Pharmaceutical Co., Ltd. 15 participants Est. completion 2021-12-09 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Enrolling by invitation NCT NCT05132660

    Treating Early Stage Diabetic Retinopathy

    Not yet reported VA Office of Research and Development 244 participants Est. completion 2028-12-31 1 site Stand-alone
    Other conditions: Diabetic Retinopathy
    View official trial listing →
  • Completed NCT NCT05148884

    Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia

    Not yet reported Neurolixis SAS 27 participants Est. completion 2023-01-18 5 sites
    Other conditions: Medication-Induced Dyskinesia
    View official trial listing →
  • Completed NCT NCT05204641

    Effect of Fecal Microbiota Transfer on Progression of Parkinson Disease

    Not yet reported Medical University of Warsaw 59 participants Est. completion 2024-10-08 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05250141

    Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product

    Not yet reported Laboratorios Andromaco S.A. 44 participants Est. completion 2022-02-17 1 site Stand-alone
    Other conditions: Bioequivalence
    View official trial listing →
  • Withdrawn NCT NCT05262348

    An Open-label Clinical Trial to Compare the Safety and Effectiveness of Adaptive Versus Conventional Deep Brain Stimulation

    Not yet reported Newronika Est. completion 2026-12-31
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05297201

    Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients With Levodopa Induced Dyskinesia

    Not yet reported Celon Pharma SA 105 participants Est. completion 2025-01-27 16 sites
    Other conditions: Parkinson Disease, Dyskinesia, Medication-Induced
    View official trial listing →
  • Completed NCT NCT05312632

    A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea

    Not yet reported Eisai Korea Inc. 201 participants Est. completion 2023-05-25 20 sites Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05369533

    Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke

    Not yet reported, Not yet reported University of California, Los Angeles 25 participants Est. completion 2024-03-11 1 site
    Cardiovascular disease
    View official trial listing →
  • Completed NCT NCT05435729

    A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease

    Not yet reported Sumitomo Pharma Co., Ltd. 7 participants Est. completion 2022-12-02 1 site Stand-alone
    Other conditions: Levodopa-induced Dyskinesia, Parkinson's Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05463367

    Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure

    Not yet reported Northwestern University 60 participants Est. completion 2025-06-01 1 site Stand-alone
    Other conditions: Opioid Use, Opioid Dependence, Opioid-use Disorder, Narcotic Use, Back Pain, Back Injuries, Chronic Pain, Chronic Low-back Pain, Pain, Chronic, Pain;Back Low;Chronic, Pain, Back
    View official trial listing →
  • Completed NCT NCT05471609

    Sustained Release Oral Formulation for Treatment of Parkinson's Disease

    Not yet reported University of Minnesota 6 participants Est. completion 2025-08-14 1 site Stand-alone
    Other conditions: Healthy Volunteers
    View official trial listing →
  • Completed NCT NCT05487300

    Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease

    Not yet reported, Not yet reported University of Utah 40 participants Est. completion 2023-05-01 1 site
    Other conditions: Parkinson Disease, Orthostatic Hypotension
    View official trial listing →
  • Status unknown NCT NCT05492019

    Effect of Doxycycline in Levodopa Treated Parkinson's Disease Patients

    Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 60 participants Est. completion 2023-01-01 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05499572

    Usability of Levodopa Cyclops™ vs INBRIJA® in Parkinson's Patients

    Martini Hospital Groningen 16 participants Est. completion 2024-07-02 1 site
    Other conditions: Usability
    View official trial listing →
  • Completed NCT NCT05523791

    Whey Protein Supplementation in Patients With Parkinson's Disease

    Not yet reported Ospedale Generale Di Zona Moriggia-Pelascini 51 participants Est. completion 2022-06-30 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05560009

    An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas

    Mayo Clinic 9 participants Est. completion 2024-07-09 1 site
    Other conditions: Recurrent Soft Tissue Sarcoma, Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma
    View official trial listing →
  • Status unknown NCT NCT05579379

    DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Support Dopaminergic Desensitization in PD

    University Hospital Tuebingen 20 participants Est. completion 2024-09
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05585827

    Online Cognitive Behavioral Therapy for Depressive Symptoms in Parkinson's Disease

    Not yet reported Helse Stavanger HF 11 participants Est. completion 2024-11-27 1 site
    Other conditions: Parkinson Disease, Depressive Symptoms, Anxiety
    View official trial listing →
  • Completed NCT NCT05708274

    Pharmacological Agents for Chronic Spinal Cord Injury (SCI)

    Not yet reported Bronx VA Medical Center 25 participants Est. completion 2025-10-30 1 site Stand-alone
    Other conditions: Spinal Cord Injuries
    View official trial listing →
  • Status unknown NCT NCT05752240

    Transcranial Direct Current Stimulation of the Primary Motor Cortex to Treat Levodopa-induced Dyskinesias

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 32 participants Est. completion 2025-03-10 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05766813

    Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease

    Not yet reported Intra-Cellular Therapies, Inc. 79 participants Est. completion 2025-11-04 35 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05781321

    Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study

    Not yet reported Mayo Clinic 170 participants Est. completion 2028-11-30 8 sites
    Other conditions: Glioblastoma
    View official trial listing →
  • Completed NCT NCT05781711

    Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease

    Not yet reported Tanta University 60 participants Est. completion 2024-08-20 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT05795088

    Continuous Theta Burst Stimulation as Potential Biomarker of Levodopa-induced Dyskinesias in Parkinson's Disease

    Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 60 participants Est. completion 2025-02-28 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Active, not recruiting NCT NCT05808504

    Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease

    Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 90 participants Est. completion 2027-09-29 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05885360

    Istradefylline Effect Protocol on Parkinson's Disease Tremor

    Not yet reported Georgetown University 27 participants Est. completion 2025-02-21 1 site Stand-alone
    Other conditions: Parkinson Disease, Tremor
    View official trial listing →
  • Completed NCT NCT05901350

    The Correlation of Reduction of Levodopa and Non-motor Symptoms of Parkinson's Disease After Deep Brain Stimulation

    Not yet reported Qilu Hospital of Shandong University 338 participants Est. completion 2023-01-01 1 site Stand-alone
    Other conditions: Parkinson Disease, Visual Impairment
    View official trial listing →
  • Status unknown NCT NCT05959044

    Effect of Folic Acid in Levodopa Treated Parkinson's Disease Patients

    Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 60 participants Est. completion 2024-07-16 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT05962957

    Role of Pentoxifylline and Celecoxib in Parkinsonism

    Not yet reported Mostafa Bahaa 80 participants Est. completion 2024-09-20 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT05976737

    Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in Healthy Chinese Subjects

    Not yet reported The Affiliated Hospital of Qingdao University 68 participants Est. completion 2024-07-12 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Terminated NCT NCT06003608

    Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease

    Nimble Science Ltd. 51 participants Est. completion 2025-01-01 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT06021756

    Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease

    Not yet reported University of Arizona 9 participants Est. completion 2023-08-25 1 site
    Other conditions: Levodopa-Induced Dyskinesia, Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT06034158

    Molecular Basis of Loss Aversion

    Not yet reported Sir Run Run Shaw Hospital 60 participants Est. completion 2024-09-01 1 site
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06037590

    A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA®

    Not yet reported PureIMS B.V. 26 participants Est. completion 2023-10-27 1 site Stand-alone
    Other conditions: Parkinson, Parkinson Disease, Parkinson's Disease and Parkinsonism
    View official trial listing →
  • Active, not recruiting NCT NCT06107426

    Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease

    AbbVie 427 participants Est. completion 2029-05 68 sites
    Other conditions: Parkinson's Disease (PD)
    View official trial listing →
  • Completed NCT NCT06113640

    Montelukast in Parkinson Disease

    Not yet reported, Not yet reported Mostafa Bahaa 60 participants Est. completion 2026-08-20 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT06115538

    Comparison of Dopamin Level in Idiopathic Parkinson's Patients

    Not yet reported Ankara Ataturk Sanatorium Training and Research Hospital 96 participants Est. completion 2025-04-30 1 site
    Other conditions: Parkinson Disease, Treatment Adherence
    View official trial listing →
  • Status unknown NCT NCT06180720

    Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects

    Not yet reported The Affiliated Hospital of Qingdao University 36 participants Est. completion 2024-11-20 Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT06219915

    Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Placebo-Controlled Arm

    Not yet reported, Not yet reported University of Michigan 13 participants Est. completion 2024-05-30 2 sites Stand-alone
    Other conditions: Parkinsonian Signs in Older Persons
    View official trial listing →
  • Status unknown NCT NCT06225869

    Effect of Dopamine on Specific Processing of Shame and Embarrassment in Parkinson's Disease

    University Hospital, Geneva 30 participants Est. completion 2025-12 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT06236230

    Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease

    Not yet reported Second Affiliated Hospital of Soochow University 60 participants Est. completion 2024-12-31 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Active, not recruiting NCT NCT06240624

    Mapping Levodopa Effects on Cortico-basal Ganglia Circuit Function in Parkinson's Disease

    Danish Research Centre for Magnetic Resonance 75 participants Est. completion 2025-12-31 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT06275633

    Behavioural Profiling of Disease-related Cognitive and Motor Impairment in PD

    Not yet reported University Hospital Bispebjerg and Frederiksberg 68 participants Est. completion 2023-07-30 1 site Stand-alone
    Other conditions: Parkinson Disease, Medication, UPDRS, Motor Function, Cognitive Impairment, Depression, Impulsive, Levodopa
    View official trial listing →
  • Status unknown NCT NCT06301282

    Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease

    University Hospital, Geneva 30 participants Est. completion 2025-12 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Status unknown NCT NCT06365190

    Effects of a Periodic Repetitive Transcranial Magenetic Stimulation in Parkinson Disease

    Not yet reported Anhui Medical University 47 participants Est. completion 2024-07-31 1 site
    Other conditions: Transcranial Magnetic Stimulation, Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT06365515

    Dopamine, Reward Learning and Sex Hormones

    Not yet reported University Hospital Tuebingen 90 participants Est. completion 2025-12 1 site Stand-alone
    Other conditions: Hormonal Changes, Menstrual Cycle
    View official trial listing →
  • Completed NCT NCT06432309

    Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease

    Not yet reported University Hospital of Ferrara 22 participants Est. completion 2024-04-25 1 site
    Other conditions: Parkinson Disease, Effect of Drug
    View official trial listing →
  • Completed NCT NCT06587217

    Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Supplemental Open-Label Arm

    Not yet reported, Not yet reported University of Michigan 5 participants Est. completion 2025-04-03 2 sites Stand-alone
    Other conditions: Parkinsonian Signs in Older Persons
    View official trial listing →
  • Status unknown NCT NCT06612593

    Cilostazol in Parkinson's Disease

    Not yet reported Ain Shams University 50 participants Est. completion 2025-10-01 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT06614153

    Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 61 participants Est. completion 2024-03-04 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Status unknown NCT NCT06626152

    Measuring Psychomotor Response to L-DOPA Challenge As a Biomarker for Outcomes in Late-Life Depression: a Pilot Feasibility Trial

    Not yet reported University of British Columbia 50 participants Est. completion 2026-05-30 1 site Stand-alone
    Other conditions: Major Depressive Disorder
    View official trial listing →
  • Completed NCT NCT06722729

    A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease

    Not yet reported Kissei Pharmaceutical Co., Ltd. 178 participants Est. completion 2026-01-14 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT06729658

    Dopamine and Brain Computer Interface

    Not yet reported Max Planck Institute for Human Cognitive and Brain Sciences 22 participants Est. completion 2024-08-06 1 site Stand-alone
    Other conditions: Healthy Participants
    View official trial listing →
  • Not yet recruiting NCT NCT06762028

    Exploring the Relationship Between L-dopa Responsiveness and Small Intestinal Microbiome in Parkinson's Disease

    University of Calgary 100 participants Est. completion 2027-07-01
    Other conditions: Parkinson Disease
    View official trial listing →
  • Not yet recruiting NCT NCT06936254

    One-Year Effect on Levodopa Equivalent Daily Dose of Thalamic VIM Nucleus Stimulation Compared to Subthalamic Nucleus Stimulation in Patients With Parkinson's Disease

    Central Hospital, Nancy, France 94 participants Est. completion 2026-09-30 1 site
    Other conditions: Parkinson Disease (PD), Deep Brain Stimulation
    View official trial listing →
  • Completed NCT NCT06954662

    A Targeted Amino Acid Supplement for People With Parkinson's Disease

    Not yet reported UConn Health 3 participants Est. completion 2025-07-17 1 site Stand-alone
    Other conditions: Parkinson Disease, Idiopathic
    View official trial listing →
  • Completed NCT NCT06976346

    Relative Bioavailability Study of HRG2010 in Healthy Subjects

    Not yet reported Jiangsu HengRui Medicine Co., Ltd. 16 participants Est. completion 2021-10-07 1 site
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Completed NCT NCT07001150

    Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease

    Not yet reported Tanta University 50 participants Est. completion 2026-05-30 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Active, not recruiting NCT NCT07055958

    Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients

    Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 74 participants Est. completion 2025-07-20 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07267065

    AAV2-hAADC for Parkinson's Disease (PDCS-01)

    Not yet reported Russell Lonser 9 participants Est. completion 2029-03-01 1 site Stand-alone
    Other conditions: Parkinson's Disease (PD), Early Onset Parkinson Disease
    View official trial listing →
  • Terminated NCT NCT07313176

    Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease

    Britannia Pharmaceuticals Ltd. 1 participants Est. completion 2026-08-31 4 sites
    Other conditions: Advanced Parkinson Disease
    View official trial listing →
  • Enrolling by invitation NCT NCT07375693

    Effect of Melatonin on Oxidative Stress Parameters in Levodopa-Treated Parkinson's Disease Patients

    Not yet reported Bangladesh Medical University 70 participants Est. completion 2026-09-15 1 site
    Other conditions: Parkinson Disease
    View official trial listing →
  • Active, not recruiting NCT NCT07403799

    REal-life ON PARKinson's - ITaly (REONPARK-IT)

    Bial - Portela C S.A. 200 participants Est. completion 2029-06-30 20 sites
    Other conditions: Parkinson Disease
    View official trial listing →
  • Completed NCT NCT07405268

    Evaluation of the Effects of Levodopa-Benserazide Drug Combination on Periodontal Status in Patients With Parkinson's Disease

    Saglik Bilimleri Universitesi 136 participants Est. completion 2026-11-13 1 site
    Other conditions: Parkinson Disease (PD), Periodontitis, Periodontal Diseases
    View official trial listing →
  • Completed NCT NCT07442591

    A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants

    Not yet reported Shanghai WD Pharmaceutical Co., Ltd. 12 participants Est. completion 2026-04-23 1 site Stand-alone
    Other conditions: Healhty
    View official trial listing →
  • Completed NCT NCT07444892

    Levodopa for Diabetic Retinopathy

    Not yet reported Emory University 230 participants Est. completion 2025-11-17 1 site Stand-alone
    Other conditions: Diabetic Retinopathy
    View official trial listing →
  • Enrolling by invitation NCT NCT07567599

    Deep Brain Stimulation in Parkinson's Disease: Motor and Functional Outcomes

    Not yet reported Federal University of Minas Gerais 40 participants Est. completion 2027-02 1 site Stand-alone
    Other conditions: Parkinson Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07647913

    Rhythm Psychophysics With Parkinson's Patients

    Not yet reported McMaster University 34 participants Est. completion 2027-10-31 1 site Stand-alone
    Other conditions: Parkinson Disease(PD)
    View official trial listing →
  • Not yet recruiting NCT NCT07748715

    Brain Dopamine Biomarker

    University of South Florida 50 participants Est. completion 2027-09-30
    Other conditions: Parkinson Disease, Healthy Adult Participants
    View official trial listing →
  • Not yet recruiting NCT NCT07793461

    Gastrointestinal Dopamine Decarboxylase and Levodopa Pharmacokinetics

    Not yet reported Beth Israel Deaconess Medical Center 40 participants Est. completion 2030-12 1 site Stand-alone
    Other conditions: Parkinson's Disease
    View official trial listing →
  • Not yet recruiting NCT NCT07806019

    Metformin in Parkinson's Disease: Safety and Efficacy

    Not yet reported Jinnah Medical & Dental College 70 participants Est. completion 2027-02-01
    Other conditions: Parkinsons Disease (PD)
    View official trial listing →
  • Completed NCT NCT07917546

    Early COMT Inhibition in PD

    Not yet reported Neuromed IRCCS 46 participants Est. completion 2025-12-31 1 site Stand-alone
    Other conditions: PARKINSON DISEASE (Disorder)
    View official trial listing →
  • Not yet recruiting NCT NCT07925086

    Magnetic-Resonance Guided Focused Ultrasound Pallidothalamic Tractotomy for Parkinson's Disease

    Not yet reported Research Center of Neurology, Russia 168 participants Est. completion 2032-01-25 1 site Stand-alone
    Other conditions: Parkinson Disease (PD)
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources

Also known as: Sinemet CR, Levodopa

Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.